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1. INTRODUCTION 
Human beings are living in an open environment which is heavily 
contaminated with many pollutants. They are constantly exposed to varieties of 
physical, chemical, and environmental factors that cause adverse effects and 
damages on human. In nature our body has different strategy to control the above 
mentioned factors, and man is constantly trying to find and identify remedies for 
these problems. Plants are used since very ancient time to control different types of 
problem associated with human. There are reports that plants contain remedies for 
various diseases including AIDS, cancer, and diabetes (Ongradi et al., 1999, 
Vijayvargia et al., 2000, Wu et al., 2001). The use of plant-based medicines for 
healing is an ancient and universal as medicine itself. Until the dawn of this century, 
natural products have served as the mainstay of all medicines world-wide. Although 
herbalism has declined in the West, it continues to exist throughout the developing 
world. According to WHO, over 70% of the world population still relies on herbal 
remedies for their health care needs (Atta-ur-Rahman and Choudhary, 1999). 
Today there are a huge number of chemical substances derived from plants that are 
considered as important drugs currently in use in one or more countries in the world 
Many of the plant products exert some effect on immune system. They either 
enhance immune response to help body clear undesirable agents from body or 
suppress immune response to control deterioration in the body. Compounds that 
alter immune response are considered Immuno modulatory agent. 
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The ubiquitous enemy:  
Microbes are able to survive on animal and plant products by releasing 
digestive enzymes directly absorbing the food, and / or by growth on living tissues 
(Extra cellular), in which case they are simply bathed in nutrients. Other microbes 
infect (Invade) animal / human cells (intracellular), where they not only survive, but 
also replicate, utilizing host-cell energy sources.  
Both extra cellular and intercellular microbes can grow, reproduce and infect 
other individuals. They are many different species of microbes and larger organisms 
(such worms) which invade humans, some of which are relatively harmless and 
some even helpful (e.g. E.coli in our intestines). Many other causes diseases (human 
pathogens, and there is a constant battle invading microbes and immune- system. 
Some microbes can even cause the death of their hosts, although this should not be 
the property of the most successful microbes. The range of organisms that can infect 
humans. E.g. HIV. 
Range of infectious organisms  
Worms (Helminthes) : e.g. Tape worms, Filaria  
Protozoan : e.g. Trpanosomes, Leishmania, Malaria  
Fungi  : e.g. Candida, Aspergillus.  
Bacteria  : e.g. E.coli, Staphylococcus,  
  Streptococcus, Mycobacteria  
Viruses : e.g. Polio. Pox viruses, Influenza, 
Hepatitis-B, HIV 
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External defenses  
I) Physical barriers to entry of microbes  
Before a microbe or parasites can invade the host and causes infections, it 
must first attach to and penetrate the surface epithelial layers of the body. Organisms 
gain entrance into the body by an active or passive means. For example, they mighty 
or burrow through the skin, or be ingested in food, inhaled into the respiratory tract 
or penetrate through an open wound. In practice, most microbes take advantage of 
the fact that we have to breathe and eat to live and therefore enter the body through 
the respiratory and gastrointestinal tract. Whatever their point of entry, they have to 
pass across physical barriers such as the dead layer of the skin or living epithelial 
cells layers which lines the cavities in contact with the exterior such as the 
respiratory, genitourinary tract or gastrointestinal tract . In fact, the main entry of 
microbes into the body is via these tracts.  
ii) Secretions  
Verities of secretions at epithelial surfaces are important in defense. The 
overall aim is to provide a hostile environment for microbial habitation. Some 
substances are known to directly kill microbes e.g. lysozymes by digesting 
proteloglycans in bacterial cell walls: other competes for nutrients (e.g. transferring, 
Fe), and others interfere with ion transport (e.g. NaCl).  Mucus (containing mucin) 
secreted by the mucosal epithelial cells coat their surfaces and make it difficult for 
microbes to contact and bind to them-a prerequisite for entry in to the body.  
The washing action of tears, Saliva and urine also help to prevent attachment 
of microbes to the epithelial surfaces. In addition, tears and saliva contain IgA 
antibodies which are secreted across epithelial cells and prevent the attachment of 
microbes. These antibodies are also present in genitourinary tract. Gastrointestinal, 
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respiratory epithelia and Phagocytes throughout the body are also known to produce 
a number of small peptides which have potent anti-bacterial properties (Peptide 
antibiotics).  
iii) Microbial products and competition  
Normal commensals (non pathogenic bacteria) also help to protect from 
infection. These non pathogenic microorganisms are found on the skin, in the mouth 
and in the reproductive and gastrointestinal tract. The gastrointestinal tract contains 
many billions of bacteria that have a symbiotic relationship with the host. These 
bacteria help to prevent pathogens from colonizing and releasing antibacterial 
substances such as colicins (anti bacterial proteins) and short- chain fatty acid. 
1.1 The Immune System 
Immune system is a remarkably sophisticated adaptive defense system within 
vertebrates, to protect them from invading agents and cancer. It is able to generate 
varieties of cells and molecules capable of recognizing and eliminating limitless 
varieties of foreign invaders. Functionally the immune system is divided into two 
interrelated activities, recognition and response. Immune system is able to recognize 
foreign substances, and discriminate foreign molecules from own cells and proteins. 
Once foreign molecule or organism is recognized, immune system responds to 
eliminate or neutralize these by utilizing the initial recognition information. The 
same response could be repeated if the immune system encounters the same antigen 
(memory response) (Kuby, 1994). On the other hand the immune system at certain 
times attack or mistakenly respond to the own tissues, that may result in 
autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and juvenile 
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diabetes (Masakuni and Toru, 1994). Similarly an immune system responds to a 
transplanted organ from a donor and result in Graft vs. host disease (Kuby, 1994).  
Immune system is a complex organization of white blood cells, antibodies, and 
blood factors that protects the body from foreign invaders, while simultaneously 
maintaining self-tolerance. A series of specialized epithelial and stromal cells also 
provide the anatomic environment which regulate various functions of immune 
system by secreting several critical factors. The immune system is a network of 
cells, tissues, and organs that work together to defend the body against attacks by 
“foreign” invaders. These are primarily microbes (germs) -tiny, infection-causing 
organisms such as bacteria, viruses, parasites, and fungi. Because the human body 
provides an ideal environment for many microbes, they try to break in. It is the 
immune system’s job to keep them out or, failing that, to seek out and destroy them. 
 
Fig. 1 Special Cells Responsible For Immune System 
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The immune system is a system of biological structures and processes within 
an organism that protects against disease. Disorders of the immune system can result 
in autoimmune diseases, inflammatory diseases, cancer and immunodeficiency. 
Immuno modulation is a procedure which can alter the immune system of an 
organism by interfering with its functions; if it results in an enhancement of immune 
reaction, it is named as an immunostimulative drug which primarily implies 
stimulation of non-specific system. Immunosuppressant implies mainly to reduce 
resistance against infections, stress and may occur on account of environmental or 
chemotherapeutic factors. Immunostimulation and immunosuppression both need to 
be considered in order to regulate the normal immunological functioning. Hence 
both immune stimulating agents and immune suppressing agents have their own 
standing, so search for better agents exerting these activities is becoming the field of 
major interest all over the world. 
A number of Indian medicinal plants and various ‘Rasayana’ have been 
claimed to possess Immunomodulatory activity .The use of plant products as 
immunomodulators is still in a developing stage. A variety of plant-derived 
materials such as polysaccharides, lectins, peptides flavonoids and tannins have been 
reported to modulate the immune system. Since ancient times, several diseases have 
been treated by administration of plant extracts based on traditional medicine. 
Natural adjuvants, synthetic agents, antibody reagents are used as 
immunosuppressive and immunostimulative agents. But there are major limitation to 
the general use of these agents such as increased risk of infection and generalized 
effect throughout the immune system. 
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1.2 The Organs of the Immune System:  
The immunological system is comprised of the lymphoid tissues and organs of 
the body. Immune cells have two main sites for their origin, and proliferation or 
activation (where they are located to target the foreign particles). These are the 
primary lymphoid organ and the secondary lymphoid organ (Levinson and Jawetz, 
1992). 
a) Primary lymphoid Organ 
Thymus gland and the bone marrows produce the specialized lymphocytes 
(T-cells and B-cells) and dispatch them through the lymph vessels to the secondary 
organs for their maturation, proliferation and storage. The bone marrow (soft tissue 
located in the cavities of the bones), produce and differentiate blood cells. It is the 
source of stem cells, which differentiate leukocytes. From the bone marrow 
lymphocytes (T Cell ) are sent to the thymus gland to mature, and are then stored in 
the secondary organs of the lymph system and in the blood stream. B-cells get 
matured and differentiated in the bone marrow then send to the secondary organs 
(Reeves, 1987).  
b) Secondary Organs  
Secondary Organs are the lymph nodes, spleen, tonsils, and Peyer's patches 
in the small intestines, liver, and appendix. They are the locations where the 
molecular parts of the immune system gather in readiness to do battle with germs, 
viruses, and allergens (Reeves, 1987).  
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Specialized Cells of the immune system 
There are several types of cells responsible for specialized function in the 
immune system, they are mainly classified as two major cell type: leucocytes and 
lymphocytes. 
Leucocytes  
Leucocytes (White blood cells) are the main cells of the immune system 
provide either innate or specific adaptive immunity. They are motile with 
specialized functions. The number of leucocytes in normal blood ranges between 
4,500 and 11,000 per mm3. Most of the leucocytes are outside the circulation, and 
the few in the bloodstream are in transit from one site to another. They are further 
classified into granulocytes, monocytes, and lymphocytes (Mosman and Coffman, 
1989). 
The most numerous of the leucocytes are important mediators of the 
inflammatory response. There are three types of granulocytes: neutrophils (50-70 
%), eosinophils (1-4 %), and basophils (0.5 %) (Kuby, 1994).  
Neutrophils  
One of the major types of cells that recruit to ingest, kill and digest 
pathogens. They live only a few hours in the blood, some migrate to the tissues to 
areas of infection or injury. Neutrophils engulf and digest bacteria and other 
microorganisms and microscopic particles.  
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Eosinophils  
Eosinophils are also motile and phagocytic , and migrate into the tissues. 
They are particularly important in the defence against parasites, and they participate 
in hypersensitivity and inflammatory (allergic) reactions. Their cytotoxicity is 
mediated by cytoplasmic granules.  
Basophils 
They have many large cytoplasmic granules, which contain heparin and 
histamine. When aggravated, they release histamine and other mediators that involve 
in allergic reactions. They also produce cytolcines. Basophils display high affinity 
surface membrane receptors for Ig E antibodies (Roitt et al., 1998).  
Monocytes 
Monocytes are also produced in the bone marrow. They constitute up to 10 
% of the blood leucocytes. However, the majorities leave; the blood after a few 
hours and migrate into almost all tissues, where they develop into macrophages. 
Both monocytes and macrophages are highly adherent, motile and phagocytic. They 
marshal and regulate other cells of the immune system. They serve as antigen 
processing-presenting cells and act as Cytotoxic cells when armed with specific IgG 
antibodies. 
Natural killer (NK) cells  
The term natural is used because NK cells are present without previous 
immunization and act immediately on target cells. NK cell lacks antigen specific 
receptors that are typical of B and T cells. They are part of innate immunity, 
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important in elimination of tumours and virus-infected cells. NK cells are derived 
from the bone marrow and can be distinguished by characteristic of azurophilic 
granules in their cytoplasm. NK cells destroy the target not only by the NK cell-
mediated cytotoxicity but can also mediate antibody-dependent cellular cytotoxicity 
(ADCC) via binding to the Fc portion of IgG on target cells. They represent only a 
small fraction of peripheral blood cells and a small fraction of lymphoid cells in the 
spleen and other secondary lymphoid tissues. NK cells have no antigen-specific 
receptors. Their Cytotoxic activity is inhibited by encounter with self-MHC 
molecules through inhibitory receptors on their surface that recognize class I. They 
thus kill self cells that have down regulated class I molecule expression 
(Cederbrant et al., 2003). Treatment of target cells with IFN-Ȗ increases expression 
of MHC class I, whereas this increased expression of MHC class I increases the 
susceptibility to TCTL-cell-mediated lysis, it actually protects against NKmediated 
lysis. Thus there are generally opposite requirements of TCTL and NK cells for 
targeting cells, TCTL cells require MHC class I recognition for killing and NK cells 
are active against targets that do not express MHC class I. In addition to the anti-
tumor activities of NK cells, they have been reported to play an important role in 
limiting the growth or spread of a variety of microbial infections. NK cells may also 
be involved in regulating haematopoiesis as well as immunoregulatory role via the 
production of a variety of cytokines (Sell, 2001).  
Lymphocytes 
Lymphocytes are small white cells found in lymphoid organs and in the blood. 
They get to the blood stream from the lymph nodes, which function to trap antigens 
and filter them out of the lymph fluid. Lymphocytes constitute about 25-50 % of the 
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blood leucocytes. They are non-motile and enter the circulation through lymphatic 
channels. Some lymphocytes leave and renter the circulation, surviving for many 
years. They are found in large numbers in the secondary lymphoid organs. When 
stimulated by antigen for example or a microbe, lymphocyte divides several times 
into daughter cells and eventually generates a clone of identical lymphocytes. Some 
of these cells remain in the circulation; others patrol the tissues of the body. The 
larger number of lymphocytes capable of reacting to the same microbe is responsible 
for the immunological memory that is manifested, if the body encounters the same 
microbe later in life. Lymphocytes are divided into two main classes according to 
their origin and differentiation. T-Lymphocytes which are produced in the bone 
marrow pass through the thymus to get mature. The other class is the B-
lymphocytes; they do not pass through thymus but get mature in gut associated 
lymphoid tissues (GALT), which in mammalian are equivalent to the bursa of 
Fabricius in birds (Mosman and Coffman, 1989).  
I. T – Lymphocytes:  There are two major classes of T-lymphocytes: T helper 
(Th) and T- cytotoxic lymphocytes (Tc).  
T helper (Th) lymphocytes regulate the antibody-forming function of B-
lymphocytes and participate in rejection of transplants. They posses CD4 surface 
molecules (also called CD4 cells). T helper cells are functionally further subdivided 
into at least two types, Th-1 and Th-2.  
The other T lymphocytes those involved in the defenses against virus 
infection, is called T-cytotoxic lymphocytes (Tc) or T-suppressor (Ts).  
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Cytotoxic T (Tc) cells are capable of destroying a target cell, that is infected 
with virus or that expresses some form of foreign antigen. These cells are the major 
immune effecter of the cellular immune response. They also express CDs molecules 
(Levine et al., 1998).  
T-suppressor (Ts) cells act to diminish helper T-cell activity; they directly 
kill virus infected or cancer cells when the battle is over. They express CD8 
molecules. In contrast to helper T cells, Ts cells down-modulate immune responses. 
Thus, the combination of helper and suppressor cells determines the level of the 
immune response to any specific antigen (Levine et al., 1998).  
II. B- lymphocytes 
They have a relatively short life span compared to T-cells. As B-cells 
mature, they turn into antibody-producing plasma cells found in lymph nodes 
and in the spleen. Once the B-cells have created a specific antibody to attack 
a specific pathogen, their primitive intelligence remembers this information 
and will know it later (Levine et al., 1998) 
The ubiquitous enemy 
Microbes are able to survive on animal and plant products by releasing 
digestive enzymes directly absorbing the food, and / or by growth on living tissues 
(Extra cellular), in which case they are simply bathed in nutrients. Other microbes 
infect (Invade) animal / human cells (intracellular), where they not only survive, but 
also replicate, utilizing host-cell energy sources.  
Both extra cellular and intercellular microbes can grow, reproduce and infect 
other individuals. They are many different species of microbes and larger organisms 
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(such worms) which invade humans, some of which are relatively harmless and 
some even helpful (e.g. E.coli in our intestines). Many other causes diseases (human 
pathogens, and there is a constant battle invading microbes and immune- system. 
Some microbes can even cause the death of their hosts, although this should not be 
the property of the most successful microbes. The range of organisms that can infect 
humans e.g. HIV. 
Immunity  
The system consists of innate components that act rapidly (within hours) but 
non-specifically (Innate Immunity - involves granulocytes, macrophages and natural 
killer (NK) cells for examples) and adaptive or acquired components that act 
specifically, but need time to respond (adaptive immunity - mediated by 
lymphocytes, initiate in 4-7 days). 
Innate immunity 
Innate immunity is considered to be antigen independent that occurs without 
prior exposure to antigens. It can be triggered upon the initial encounter with a 
foreign substance; its components are often called the first line of defence.  Skin is 
considered as a component of innate immunity. Similarly, the following bodily 
functions contribute to host defence and are considered parts of innate immunity: the 
lysosomal enzymes in salivary, lacrimal and vaginal secretions, which have 
bacteriostatic properties, the cough reflex, which is an important mechanism to clear 
the bronchial passages of irritants and potential infectious microbes, and the fever 
response, which is an important reaction to an infection.  Important components of 
the innate immune defence system include phagocytic cells such as Neutrophils, 
macrophages, NK cells, and the soluble products, type I interferon and complement. 
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Receptors of the Innate Immune Response  
In order to detect PAMPs or DAMPs, cells need tools to recognize them. 
These tools are protein receptors that can be found on the cell surface as well as 
internally. In general, they are called pattern recognition receptors or PRRs. These 
receptors come in families consisting of multiple members. Receptors that recognize 
PAMPs include the Toll-like receptors (TLRs), the C-type lectin receptors (CLRs), 
the NOD-like receptors (NLRs), RIG-I-like receptors (RLRs) and invariant T cell 
receptors. DAMP receptors are not so clear-cut. TLRs have been implicated as well 
as the receptor for advanced glycation end products (RAGE). Also the purinergic 
receptors that recognize ATP would also fall into this category  
Toll-like Receptors  
These receptors are found on most cells of the body. They recognize a variety 
patterns associated with a number of pathogens including virus-associated nucleic acids; 
bacterial-associated cell wall components, protein, ribosomal RNA and DNA; and 
protozoan-associated proteins. The majority is found extracellular, but a number are also 
found intracellular. When stimulated they activate the transcription factor NFκB, which is 
essential for activating a cell‘s immune functions and set off a signal cascade via MAP 
kinase (a phosphorylating enzyme). 
C-type Lectin Receptors  
These receptors are specialized in recognizing carbohydrate structures, such 
as the sugar mannose, which is a common component of fungal cell walls. Thus, 
these receptors are found on the cell surface. Though much of the literature involves 
their expression on immune cells, reports of CLR variants on non-immune cells can 
also be found. On the phagocytic cells, it is known that they can participate in 
endocytosis, the engulfment of particles or pathogens and respiratory burst.15 Some 
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also appear to initiate signal cascades similar to TLRs leading to NFκB and MAP 
kinase activation, but it also appears that they can work in concert with TLRs, 
enhancing or inhibiting their function. 
NOD-like Receptors  
These receptors are found in the cytoplasm of cells. Traces of their 
expression is found in most organs of the body and it is probably safe to say that 
most immune cells express at least some members of the NLR family. These 
receptors are designed to detect intracellular bacteria and, possibly, endogenous 
stress molecules and allow the cell to produce one of the most potent inflammatory 
mediators, Interleukin (IL)-1ȕ.17  
RIG-I-like Receptors  
Like NLRs, RLRs are also found in the cytoplasm of a cell. Instead of detecting 
bacterial products, these receptors help detect viral infection. 18They do this by binding 
to RNA produced during viral replication. Working together with nucleic-acid detecting 
TLRs, they lead to NFκB, MAP kinase activation and activation of Interferon regulatory 
factor (IRF) transcription factors.19The IRF transcription factors are necessary to 
produce cytokines specialized for the control of viral infections. Cytokines are small, 
secreted proteins used as messengers between cells, which alert surrounding immune 
cells about danger. 
Immune Cells of the Innate Response  
Under epithelial layers are resident macrophages, neutrophils, dendritic cells, 
NK cells, mast cells and a number of T cell-related cells.20  
Macrophages  
The name macrophage is derived from Greek, meaning - large eaters‖. Their 
main function is to phagocytize (engulf) pathogens and particles. It does this by 
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wrapping its plasma membrane around particles until they are enveloped and 
pinched off to form an endosome inside the cell. Once inside the cell, the endosome 
merges with a lysosome that contains enzymes and acids that can digest the 
contents. Macrophages also have the ability to generate a_ respiratory burst‖, which 
is a release of oxygen radicals that damage surrounding pathogens and cells. They 
also can alert and attract other immune cells through inflammatory cytokine release. 
Neutrophils  
Neutrophils are the main foot soldiers of the innate immune response and are 
certainly the most abundant. They also have a wide arsenal of tools to deal with 
invaders. Like macrophages, neutrophils can phagocytize particles, release a 
respiratory burst and produce inflammatory cytokines. Unlike macrophages, 
neutrophils have the internal caches of anti-microbial substances called granules.22  
Dendritic Cells  
Dendritic cells are also phagocytic cells, but they have the special ability of 
initiating an adaptive immune response (will be discussed later). Unlike neutrophils 
and macrophages, Dendritic cells or DCs are not simple foot soldiers. Instead, they 
function more as spies and provide intelligence about invaders to T cells through a 
phenomenon called ―antigen presentation‖ and through cytokine production.  
NK Cells  
The NK stands for Natural Killer and the name implies their function. These 
cells, however, do not kill pathogens directly. Instead, these cells have the ability to 
recognize when other cells are harboring internal pathogens using special receptors 
and then kill them. Situations where this might occur is during viral and 
mycobacterial infections. These pathogens easily reside in host cells, finding ways 
to block lysosome fusion and their own destruction.  
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Mast Cells  
Mast cells are the cells that are responsible for the classic signs of 
inflammation, which include redness, swelling and heat. Though well known for 
their association with allergy, they also can detect PAMPs and DAMPs through 
receptors and become immunologically active. Mast cells exert their functions 
mainly through cytokine and granule release. Unlike neutrophils, which release 
antimicrobial substances, mast cells release histamine and heparin. Histamine is well 
known for its vasodilator function and ability to allow fluid to leak between cells, 
causing redness and swelling. It also causes inflammatory itching by triggering 
neurons (unmyelinated C-fibers) responsible for the itch feeling. Heparin prevents 
blood coagulation.  
T cell-like Cells  
Most T cells are part of the adaptive immune response as they have adaptive 
T cell receptors (receptors that learn to recognize pathogens). NK T cells and Ȗį T 
cells, however, use invariant T cell receptors (receptors that do not rearrange) or 
semi-invariant T cell receptors and participate in the innate immune response.  
NK T cells are similar to the NK cells mentioned above. Not so much in 
function, but more in how they look. These cells share many of the same surface 
protein markers. NK T cells, however, do not kill compromised cells. Instead, they 
are quick cytokine producers. In doing so, they quickly notify all surrounding cells 
that there is problem when they recognize PAMPs presented to them via dendritic 
cells. 
The Ȗį T cells are important for innate immune reactions and the adaptive 
immune response as they have invariant and variant T cell receptors. Their precise 
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function remains unclear, but they can secrete cytokines and, like the NK T cells 
above, participate in alerting and strengthening local immune responses.  
Non-cellular Systems of the Innate Immune Response  
Besides cells, there are also defenses in your body that are ready to react to 
pathogens as soon as they are encountered, much like booby traps. These systems 
rely on small proteins that are found within the bodily fluids.  
Complement System  
The liver synthesizes the proteins of the complement system and they work 
in concert to aid in phagocytosis, bacteria lysing and immune cell attraction. One 
can visualize it as a self-assembling machine that starts to assemble as soon as the 
first proteins are bound and in place. The complement_ machine‖ is known to be 
initiated by three different pathways: the classical pathway, the alternative pathway 
and the lectin pathway. The classical pathway is triggered when antibodies are 
bound to a pathogen. The alternative pathway is triggered when the victim is unable 
to block the cascade (normal cells can, while pathogens cannot). The lectin pathway 
uses free lectin proteins (lectins are proteins that bind sugars) to bind sugars 
associated with bacterial cell walls).  
Acute Phase Proteins  
These proteins are also produced by the liver and especially during 
inflammation when pro-inflammatory cytokines are produced. Many are designed to 
coat pathogens and have chemotactic properties (have the ability to attract cells). 
Some inhibit microbial growth by sequestering iron from the environment. The 
lectins from the lectin pathway of complement activation are considered acute phase 
proteins. 
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Anti-microbial Peptides  
Often called ―defensins, these peptides function as natural antibiotics and 
our produced by cells that guard the external surfaces and internal surfaces such as 
the skin and the gastrointestinal system. In the skin, the main sources are 
keratinocytes, mast cells, neutrophils, sebocytes and eccine epithelial cells. In the 
intestines, one of the main producers are the Paneth cells of intestinal crypts. 
Acquired immunity 
Acquired immunity is antigen dependent and comprises of all the specific 
immunological reactions associated with lymphocytes.  Acquired immunity is 
subdivided into two effector arms, humoral immunity and cell mediated immunity. 
Humoral immunity is mediated by soluble protein molecules known as antibodies 
that are produced by B lymphocytes. Antibodies are specifically recognized 
microbial antigens, neutralize the infectivity of the microbes and target microbes for 
elimination by various effector mechanisms. 
 
Fig.2 Mechanism of Immunity. 
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Humoral immunity 
The defence mechanism against extracellular microbes and their toxins, 
because secreted antibodies can bind to these microbes and toxins and assist in their 
elimination. Antibodies themselves are specialized and different types of antibodies 
may activate different effector mechanisms.  
Cell mediated immunity 
It is the result of the activity of many leukocyte actions, reactions, 
interactions that range from simple to complex. This type of immunity is dependent 
on the actions of the T (Thymus) lymphocytes, which are responsible for a delayed 
type of immune response. The T lymphocyte becomes sensitized by its first contact 
with a specific antigen. It is also called cellular immunity. 
1.4 Innate immune system  
Innate immune system The term “innate” refers to that part of the immune 
system with which we are born; that is, it does not change or adapt to specific 
pathogens(unlike the adaptive immune system). The innate immune system provides 
a rapid first line of defence, to keep early infection in check, giving the adaptive 
immune system time to build up a more specific response. Innate immunity consists 
primarily of a chemical response system called complement, and the endocytic and 
phagocytic systems, which involve roaming “scavenger” cells, such as macrophages, 
that detect and engulf extracellular molecules and materials, clearing the system of 
both debris and pathogens. 
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Fig.3 Immune Response Structure 
1.5 Adaptive immune system 
The adaptive immune system is so-called because it adapts or “learns” to 
recognize specific kinds of pathogens, and retains a “memory” of them for speeding 
up future responses. The learning occurs during a primary response to a kind of 
pathogen not encountered before by the immune system. The primary response is 
slow, often first only becoming apparent several days after the initial infection, and 
taking up to three weeks to clear an infection. After the primary response clears an 
infection, the immune system retains a memory of the kind of pathogen that caused 
the infection. Should the body be infected again by the same kind of pathogen, the 
immune system does not have to re-learn to recognize the pathogens, because it 
“remembers” their specific appearance, and will mount much more rapid and 
efficient secondary response. The secondary response is often quick enough so that 
there are no clinical indications of a re-infection. Immune memory can confer 
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protection up to the life-time of the organism (measles is a good example in this 
regard). The adaptive immune system primarily consists of certain types of white 
blood cells, called lymphocytes, which circulate around the body via the blood and 
lymph systems (Hofmeyr Steven, 2000). 
T helper Cells and Their Education  
T helper cells or Th cells are crucial cells in the adaptive immune response and 
they are characterized by a surface protein called, CD4. They hold the key to initiating 
the functions of cytotoxic T cells33 and B cells34. Furthermore, they can also increase 
the efficacy of macrophages 
Th cells interact with the MHC class II/peptide complexes presented by 
antigen presenting cells through its receptor, called the T cell receptor (TCR). If a T 
cell has never before seen antigen, it is called a naïve T cell. In this situation, the T 
cell will need instruction from a professional antigen presenting cells, usually a DC, 
about how to perform its function. DCs do this through cell surface proteins call co-
stimulatory molecules and through cytokine expression. This process is consists of 
three main signals. The first signal is the antigen recognition; the second signal is 
co-stimulation and the third cytokine exposure. This whole process is referred to as 
_ priming‖ of the naïve T cell. Once primed, the T cells begin to divide; a process 
that is referred to as expansion or proliferation.   
The most important set of co-stimulatory molecules is CD80 or CD86 on the 
DC and CD28 on the T cells. This second signal is necessary to tell the Th cell that 
there is a problem. If signal one is given without this second signal, the T cell will 
assume that the antigen is actually harmless and become non-responsive in a process 
called ―anergy‖36. Only a DC that has encountered a PAMP or another danger 
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signal will express CD80 or CD86 on its surface reassuring the Th cell that there is, 
indeed, a problem.  
Signal three is the secretion of cytokines of the DC. There are several 
cytokines important for Th cell eduction. They most important ones are IL-4, IL-12, 
IL-6, TGFȕ and IL-10. Th cells will differentiate into different types of Th cells 
depending on which cytokines prevail. The main types of Th cells are T helper 1 
(Th1) cells, T helper 2 (Th2) cells, T helper 17 (Th17) cells, and induced regulatory 
T cells (iTreg).  
Th Cell Subtypes  
Each Th cell subtype has its own unique set of skills. One could almost see 
differentiation as an occupation. Just like an athlete will choose to develop her body 
and a scientist will choose to develop her mind. In humans, these choices are 
reflected at the level of gene transcription and protein expression. The athlete will 
stimulate muscle growth and the scientist develops the cerebral cortex of the brain. 
It‘s the same for Th cell differentiation. The four main subtypes of Th cells are 
listed. There are, however, rare forms that have been observed that are not listed and 
Th cells, much like humans, can fall into gray areas between the stereotypes.  
T helper 1 Cells  
The Th1 path is chosen when T cells are exposed to IL-12 during priming. 
Th1 cells are characterized by the production of the cytokine, interferon-Ȗ (IFNȖ) 
and the expression of the master transcription factor, T-bet. Th1 cells are experts at 
gearing the immune response towards to the control of internal pathogens like 
viruses and mycobacteria, which reside internally in macrophages. They perform 
this function by initiating cytotoxic T cell responses, helping macrophages to 
become more effective, by helping B cells to produce certain types of antibodies. 
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These functions are executed, in part, through IFNȖ exposure, however, some 
require cell-cell contact and will be explained in more detail later.37  
T helper 2 Cells  
Th2 cells are created during exposure to high amounts of IL-4. This leads to 
the expression of the Th2-associated master transcription factor, GATA3. Th2 cells 
are also characterized by the production of IL-4 (indeed, the same cytokine needed 
to create them). These cells are designed to skew the immune system towards a 
humoral immune response (antibody response) that can deal with parasite infection. 
Unfortunately, Th2 responses are also the ones associated with allergy development 
as well. Th2 cells do their work by effectively helping B cells and encouraging 
specific forms of antibodies. This is done through a combination of IL-4 exposure 
and cell-cell interactions.  
T helper 17 Cells  
The Th17 subtype is the most recently described of the Th subtypes. It is 
most effective at controlling extracellular bacterial and fungi responses, like those 
found during intestinal food poisoning or during a yeast infection. Its creation is 
dictated by the cytokines IL-6 and TGFȕ and this leads to the expression of the 
master transcription factor, RORȖt. Th17 cells produce the cytokine IL-17. IL-17 
production is one of the main facilitators of their function and it encourages 
surrounding cells to increase neutrophil migration. Neutrophils are excellent 
phagocytic cells with many bacterial killing tools.  
Induced Regulatory T cells  
To those just learning about the immune system, the existence of the 
following Th subtype may be confusing. iTreg are designed to counter the functions 
of other immune cells. Why? The reason is that immune responses are highly 
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damaging to surrounding tissues and, without them, immune responses would spiral 
out of control.  
That said; these cells are induced by DCs when they are exposed to high 
amounts of IL-10 or TGFȕ. This causes the expression of the master transcription 
factor, Foxp3. In turn, iTreg produce IL-10 or TGFȕ. IL-10 and TGFȕ are what is 
called ―anti-inflammatory‖ cytokines. They have the ability to limit the functions of 
immune cells. IL-10, for instance, lowers Th1 and Th17 responses and reduces 
macrophage efficacy. TGFȕ encourages apoptosis (induced death of cells), prevents 
cell division and lowers phagocytosis 
Cytotoxic T cell Responses  
Th cells are not the only kind of T cell. Cytotoxic T cells (CTLs), 
characterized by the surface marker CD8, are not to be missed and are essential for 
the elimination of viral infections. The function of a CTL is found in its name. 
―Cyto‖ refers to cell and ―toxic‖ means just how it sounds. These cells are ―cell 
toxic‖ and kill other cells. In many ways, they are similar to the NK cells and NK T 
cells of the innate immune system. However, they do not use invariant receptors to 
recognize problems in other cells, but instead use an adaptive system.  
CTLs, like Th cells, have a TCR. This means that they can detect unique 
peptides presented to them by other cells. In the case of Th cells, these are MHC 
class II molecules presented via DCs. In the case of CTLs, they are MHC class I 
molecules. During an infection, as we earlier mentioned, DCs will travel to the 
lymph node and present samples of the intruder to the T cells. This is also happens 
for CTLs. However, despite the presence of all the priming signals, priming will be 
suboptimal. CTLs need an additional signal, jokingly called ―the license to kill‖. 
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This signal is given by a Th1 cell through the production of a cytokine called IL-2, 
which stimulates CTL expansion; and through an interaction between the Th1 cell 
and the DC via CD40 on the DC and CD40 ligand on the Th1 cell, which makes the 
DC more effective at priming CTLs33. Once a CTL is primed and active, it has the 
ability to kill.  
As you can see, CTL activity is highly controlled to ensure that they react 
only to pathogen-associated peptides. The reason is that MHC class I can be 
expressed by every cell type in the body. MHC class I on a cell is like a sign 
advertising the health of the cell. The cell is constantly displaying samples of the 
proteins it‘s making. If an active CTL recognizes one of these samples as being of 
viral origin, it kills that cell; eliminating a viral host. 
Adaptive Humoral Immune Responses  
The word - humor‖ means fluid in Latin and, therefore, humoral immune 
responses relate to non-cellular systems found in the bodily fluids. We‘ve already 
discussed non-cellular components of the innate immunity, however, in immunology 
most people are not referring to these non - cellular systems when they use the term - 
humoral immune response‖. Instead, they are referring to the immune response mediated 
by antibodies and this is part of the adaptive immune response.  
The cell behind antibody responses is the B cell. Naïve B cells of the 
immune system produce rudimentary antibodies (see below) until other cells activate 
them. B cells, unlike the T cells, are not required to interact with DCs; instead B 
cells reside in lymphoid tissues and fish for antigens that they recognize using their 
B cell receptors or BCR. The BCR looks like a surface bound antibody and once it 
binds a molecule, the B cell engulfs it and much like the phagocytes, digests it. Just 
like the DC, the B cell will then present pieces of the antigen to Th cells using MHC 
Chapter 1 Introduction 
Dept. of Pharmacology 29 JKKMMRF College of Pharmacy 
class II molecules. Primed and activated Th cells, which recognize the presented 
peptides, are then able to ―help‖ the B cell through a CD40-CD40 ligand 
interaction. The Th cell also provides cytokine signals to tell the B cell which kinds 
of antibodies it should make.  
This process is reminiscent of the priming process of Th cells. Signal one is 
the MHC class II/peptide and TCR interaction between the B cell and the T cell. 
Signal two is the costimulatory help provided by the T cell in the form of CD40-
CD40 ligand interactions. And, signal three is the cytokine message provided by the 
T cell. Helped B cells will then further differentiates into plasma cells, which can 
produce massive quantities of antibodies.  
Antibodies  
Antibodies, by themselves, cause very little harm. However, their strength 
lies in their ability to tag a molecule as harmful and block molecular functions. 
Antibodies enhance the functions of the innate immune system. They can bind to 
pathogens and particles to initiate the complement system and induce phagocytosis. 
They can also block/neutralize molecular interactions. Examples of this function 
would be an antibody that blocks the toxic effects of diphtheria toxin or antibodies 
the block viral binding sites to cells. Antibodies also interact directly with cells and 
can change their function by binding to specific antibody receptors found on the 
surfaces of immune cells. 
An Antibody is a small protein structure produced by B cells. It is also called 
an immunoglobulin (Ig). It looks like a - Y‖ and it is formed from four separate 
proteins. Each tip of the - Y‖ recognizes and sticks to the antigen, meaning that each 
antibody can bind two similar antigens. A single arm is called a Fab (Fragment, 
antigen binding) fragment. The base of the - Y‖ is called the Fc (Fragment constant) 
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region and, while the Fab fragments dictate the specificity of the antigen binding, 
the Fc region dictates the type of antibody or isotype. The antibody isotype is 
dictated by the prevalent cytokines in the environment as well as additional danger 
signals that the B cell experienced while being helped by the Th cell.41  
Rudimentary Antibodies: IgM and IgD  
The first types of antibodies that a B cell can produce are IgM and IgD . The 
- M‖ and - D‖ refers to different classes of the Fc region. IgM is found as a pentamer, 
with five individual IgM antibodies bound by their Fc regions in the center forming a 
star. They are effective at complement activation. IgD is found as a monomer and its 
function is undefined. However, it has the ability to bind mast cells via an Fcį receptor 
(į for D) and induce anti-microbial peptide secretion.  
IgG  
IgG antibodies are found as monomers and they are very potent at 
stimulating immune responses. They are capable of neutralization, inducing 
phagocytosis in macrophages and neutrophils via FcȖ receptors (Ȗ for G), activation 
of complement, and also the activation of NK cells (also via FcȖ receptors).  
IgE  
IgE antibodies are monomers. They are known to cause mast cell 
degranulation via binding of Fcİ receptors (İ for E). They are induced during 
parasite infection and, unfortunately, also during allergy.  
IgA  
IgA is found as a dimer of two antibodies attached via their Fc regions. It is 
involved with mucosal defense: found in gastrointestinal system, the respiratory 
systems. They are particularly effective at neutralization of microbes and toxins.  
How the Adaptive Response Strengthens the Innate Response Once the adaptive 
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immune system has formed a response, the body has a long-term record of the 
invading pathogen in the form of long-lived plasma cells, memory T cells (not 
covered here) and antibodies. This is why vaccination is so important. It allows your 
body to create an adaptive immune response against an invader without having to 
truly become infected.42 When a body encounters a pathogen for the second time, 
it‘s a completely different situation than the first encounter. During a second 
infection, T cells drawn to the inflammation site will have knowledge to help 
macrophages, recruit more neutrophils, and kill infected cells. Antibodies will be 
now present to assist complement activation, the phagocytosis of particles, and even 
kill microbes. The response will be quicker and more effective.  
Though separating the two types of responses: innate and adaptive, helps 
with learning; it can also become an obstacle to seeing the immune response as a 
complex, dynamic system. It is important when looking at an immunological 
problem to consider the host‘s previous history as it has so much influence on the 
immune response. 
1.6 Cytokines 
Cytokines are a group of low molecular weight regulatory protein secreted 
by leukocytes and a variety of other cells, in response to a number of inducing 
stimuli. Cytokines as general act as immune "messenger molecules" that modulate, 
educate, stimulate, and regulate various aspects of the immune response by acting on 
cells. Cytokines bind to specific receptors on the surface of target cells. Cytokines 
that are secreted from lymphocytes are termed lymphokines, whereas those secreted 
by monocytes or macrophages ate termed monokines. Many of the lymphokines are 
also known as interleukins (ILs), since they are not only secreted by leukocytes but 
Chapter 1 Introduction 
Dept. of Pharmacology 32 JKKMMRF College of Pharmacy 
also affect on leukocytes. Cytokines include interferons, stimulating factors, or 
necrosis factor. Some properties of cytokines are given below (Kuby, 1994). 
Cytokines have been reported to be involved in the immunopathology of 
several autoimmune diseases including Type 1 diabetes (Dinarello and Mier, 
1987). There is evidence that cytokines could have a direct role in N-cell death 
(Mandrup- Poulsen et al., 1986). The macrophage released cytokines, TNF-α and 
IL-1, are cytotoxic to islet N-cells in vitro (Mandrup-Poulsen et al., 1986, 
Campbell et al., 1988). Interleukin-6, also produced by macrophages, is a key 
mediator of multiple inflammatory and immune responses and regulates insulin 
secretion in vitro in concert with IL-1 (Campbell et al., 1988). IFN-y, produced by 
activated T lymphocytes, activates macrophages,enhances class I Major 
Histocompatibility Complex (MHC) antigen expression and induces class II 
expression in combination with TNF on normal cultured human islet cells (Pujol- 
Borrell et al., 1987); IFN-y also enhances TNF induced human islet cells 
cytotoxicity (Soldevila et al., 1991). These studies indicate that cytokines may have 
a role in the pathogenesis of Type 1 diabetes. The biological properties of these 
cytokines and their potential role in the pathogenesis of Type 1 diabetes will be 
discussed next 
Cytokine antagonists  
There are several proteins that can inhibit the activity of cytokines. These 
proteins act by two ways. Either the antagonist can bind to the receptor without 
activating it, or to the cytokines directly preventing their further binding to the 
receptors. The best characterized inhibitor is the   IL-1 receptor antagonist (IL-1Ra) 
which binds to the IL-1 receptor (lL-1R) without activation, and blocks it from 
Chapter 1 Introduction 
Dept. of Pharmacology 33 JKKMMRF College of Pharmacy 
binding IL-l a or ß (Dinarello, 1991). The second group of the inhibitors is the 
soluble cytokine receptors that binds to cytokine and neutralize their activity. IL-2, 
IL-4, IL-6, IL-7, INF-y, TNF-a, TNF-13, and (Leukemia inhibitory factor) are 
among the soluble cytokine receptors that have been detected (Foxwell, 1992). 
Interleukin-2 (IL-2)  
Interleukin 2 (IL-2) was one of the first well-characterized interleukin. 
Initially it was called T cell growth factor (TCGF), and its activity was detected in 
the supernatant of mitogen-stimulated peripheral blood lymphocytes (Theze, 1998). 
It is produced and secreted by activated T helper cells (CD4+), as the major 
interleukin responsible for proliferation and differentiation of T-cell and B-cell 
(Nakagawa et al., 1985 and Muraguchi et al., 1984). IL-2 alone induced the 
proliferation of T-helper 2 (Th-2) cells, which produce predominantly IL-4 and IL-5 
and generate IgGI- and IgE-secreting cells as well as eosinophilia (Romagnani, 
1992). Bogen and his colleagues (1993) observed IL-2 as one of the first cytokines 
produced in draining lymph nodes several days after immunization which supports 
the important role of IL-2 in initiating T-cell activation in lymphoid tissues. 
Interleukin-6 (IL-6)  
Interleukin-6 is an interleukin that acts as both a pro-inflammatory and anti-
inflammatory cytokine. In humans, it is encoded by the IL6 gene (Ferguson-Smith et 
al., 1988). IL-6 is secreted by T cells and macrophages to stimulate immune 
response, e.g. during infection and after trauma, especially burns or other tissue 
damage leading to inflammation. IL-6 also plays a role in fighting infection, as IL-6 
has been shown in mice to be required for resistance against bacterium 
Streptococcus pneumoniae (van der Poll et al., 1997). 
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Clinical use: IL-6 is one of the most important mediators of fever and of the acute 
phase response. It is capable of crossing the blood and brain barrier (Banks et al., 
1994) and initiating synthesis of PGE2 in the hypothalamus, thereby changing the 
body's temperature set point. In muscle and fatty tissue, IL-6 stimulates energy 
mobilization which leads to increased body temperature. IL-6 can be secreted by 
macrophages in response to specific microbial molecules, referred to as pathogen 
associated molecular patterns (PAMPs). These PAMPs bind to highly important 
group of detection molecules of the innate immune system, called pattern 
recognition receptors (PRRs), including Toll-like receptors (TLRs). These are 
present on the cell surface and intracellular compartments and induce intracellular 
signaling cascades that give rise to inflammatory cytokine production (Bastard et al., 
1999). IL-6 is relevant to many diseases such as diabetes (Kristiansen et al., 2005) 
atherosclerosis (Dubiński et al., 2007) depression (Dowlati et al., 2010) Alzheimer's 
Disease, (Swardfager et al., 2010) systemic lupus erythematosus (Tackey et al., 
2004) prostate cancer (Smith et al., 2001) and rheumatoid arthritis (Nishimoto, 
2006). 
1.8 Immunomodulation 
Immunomodulation is a very broad term which denotes to any changes in the 
immune response and may involve induction, expression, amplification or inhibition 
of any part or phase in the immune response (Sell, 1987). Modulation of the immune 
response may involve induction, expression, amplification, or inhibition of the 
afferent, central, efferent, or accessory phase of the immune response. 
Immunomodulation may be specific or nonspecific (Stewart, 1987). The 
immunomodulating drugs are needed for the treatment of various disease statuses 
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such as infections, organ transplantation, cancer, rheumatoid arthritis, systemic 
lupus erythematosus, Down syndrome, Crohn's and autoimmune diseases and the 
acquired immune deficiency syndrome (AIDS).    
        Immunomodulation is the regulation and modulation of immunity either by 
enhancing or by reducing the immune response. Modulation of immune response 
may involve induction, expression or amplification of immune response. In other 
words, immunomodulation involves a change in the human body’s immune system 
caused by agents that activate or suppress its function. If the modulation in immune 
system results in enhancement of immune reaction, it is known as the 
immunostimulation. There are two main categories of immunostimulators. The 
specific immunostimulators are those which provide antigenic specificity in immune 
response, such as vaccines or any antigen; the non-specific immunostimulators are 
those which act irrespective of antigenic specificity to augment immune response of 
other antigens or stimulate components of the immune system without antigenic 
specificity, such as adjuvants and non-specific immunostimulators (Sunil et al., 
2011). 
Most significant progress in the field of immunomodulators is represented by 
the discovery of cyclosporin. It is a potent immunosuppressant that has proved to be 
a boon for prevention of graft rejection. The drug is also gaining ground for 
treatment of several autoimmune diseases, particularly in failures of prednisolone, 
azathioprin, cyclophosphamide and methotrexate. However, due to its very low 
therapeutic index and significant nephrotoxicity, search for an alternative to 
cyclosporine is being actively pursued (Walsh et al., 1992) 
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Immunoadjuvants 
These agents are used for enhancing vaccines efficacy and therefore, could 
be considered specific immune stimulants 31 example in this regard is of Freund‟s 
adjuvant. The immunoadjuvants hold the promise of being the true modulators of 
immune response. It has proposed toexploit them for selecting between cellular and 
humoral, Th1 (helper T1 cells) and Th2, (helper T2 cells) immunoprotective and 
immunodestructive, and reagenic (IgE) versus immunoglobin G (IgG) type of 
immune responses, which poses to be a real challenge to vaccine designers. 
Immunostimulation 
These agents are envisaged to enhance body's resistance against infections 
(and may be against allergy, autoimmunity, and cancer as well). By this definition 
these agents are inherently non-specific in nature, but they can act through both the 
innate and adaptive arms of the immune response. In healthy individuals the 
immunostimulant are expected to serve as prophylactic agent i.e. as immune 
potentiates by enhancing the basal levels of immune response, and in individuals 
with impairment of immune response as immunotherapeutic agent. The immune 
compromised conditions include patients with primary (humoral, cellular or 
combined immune deficiency syndromes) as well as secondary immune deficiencies 
(AIDS, malignancy, cancer chemotherapy, patients receiving steroids etc). 
Considering that these agents may not be effective by themselves, they may be used 
as adjunct to chemotherapy to remove residual cancer cells, as well as in treatment 
of chronic/persistent/latent infections (viral, parasitic etc) with or without available 
chemotherapeutic agents. 
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Increasing urgent need to develop new effective herbal remedies or drugs for 
health care; traditional medicinal plants have recently received adequate attention of 
the western countries, pharmaceutical companies and scientific communities 
(Planning Commission, Govt. of India, 2000; Alam et al., 2004; Ladjel et al., 2011). 
Herbal formulations are effective, relatively cheaper and safe alternative treatment 
for various diseases since most of the synthetic drugs available in the market have 
more side effects and provide only symptomatic relief (Fulzele et al., 2002). The 
present scenario thus forces hard to discover newer drugs from our broad 
biodiversity rich reservoir of plant kingdom which may provide therapeutic cure and 
would be free from undesirable side effects as well as economical, which would 
easily be accepted by the developing nations. 
Many of the plant products exert their effect through immune system; hence, 
a number of plant species, to days, are being investigated for their products in 
development of immune response modifiers or Immunomodulators (Upadhyay, 
1997). Treatment and prevention of infectious diseases are the most common 
reasons to use immunomodulators. These sorts of agents are becoming very popular 
in the worldwide natural health industry as people have started realizing the 
importance of a healthy immune system in maintenance of health and prevention 
and recovery of disease since immunomodulators do not tend to boost immunity but 
to normalize it (Sehar et al., 2008; Agrawal et al., 2010). The mode of action of 
immunomodulators in the body is still largely a mystery, however, a part of their 
beneficial effects appears to be because of their ability to naturally increase the 
production of cytokines, which mediate and regulate the immune system. The 
primary target of most of the immunomodulatory compounds are believed to be 
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macrophages, which play a key role in the generation of immune response. 
Activated macrophages produce a number of intermediates of reactive oxygen 
species (ROI/ ROS) and nitric oxide (NO) that have antimicrobial activity (Sharp et 
al., 1993; Drapier, 1997; Syamsudin et al., 2008). Continued discovery of new 
immune regulators and increased understanding of immunity will ensure newer 
opportunities for the use of immunomodulators in medical science. 
Immunomodulators have the ability to mount an immune response or defend 
against pathogens or tumors and can safely be used to alleviate hyper- or hypo- 
immune responses or against various diseases that accompany immune suppression 
viz. Acquired Immune Deficiency Syndrome (AIDS), Leishmaniasis, Filariasis, 
Tuberculosis and Malaria (Wagner, 1990; Dwivedi et al., 2008; Samant et al., 2009; 
Singh et al., 2009; Mahiuddin et al., 2010; Patel et al., 2010). Immunomodulators 
may also serve as immunological adjuvants to presently available standard drugs or 
vaccines to boost their efficacy (Mahiuddin et al., 2010). The capacity of adjuvants 
to activate antigen presenting cells (APCs) during induction of primary immune 
response is of critical importance for development of protective immunity against a 
number of pathogens which can be cured by these immune modifiers when used 
prophylactically.  
In spite of the availability of drugs against several diseases newer agents are 
required to fulfill drawbacks of the currently used drug and to combat drug 
resistance commonly encountered or fast emerging against some pathogens. A 
number of plants have been identified to possess immunomodulatory or therapeutic 
efficacy and even active chemical constituents have also been identified, however, 
many still remain unexploited and need thorough investigation viz. Annona 
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squamosa (AS), Murraya koenigii (MK), Withania coagulans (WC) and some 
chemo-types of Withania somnifera (WS) which are widely consumed by human 
population in India. 
Annona squamosa L. (Family: Annonaceae), commonly known as Custard 
Apple or Sugar Apple or ‘Shareefa’ is a native of West Indies and is cultivated 
throughout India, mainly for its edible fruit. The plant is attributed with several 
medicinal properties which include antifertility and anti-tumour activities in mice 
and rats (Rao et al., 1979; Asolkar et al., 1992; Yang et al., 2008). The fruit pulp 
due to its richness in free sugars, minerals and vitamins is known to serve as blood 
tonic (Rao, 1974). The young leaves of AS are used extensively for its antidiabetic 
activity by tribal men in and around the villages of Aligarh district in the state of 
Uttar Pradesh, India (Atique et al., 1985) and also by the people of Chota Nagpur 
district in the state of Bihar, India (Topno, 1997).  
Murraya koenigii (Family: Rutaceae), commonly known as Curry-leaf tree is 
found almost everywhere in the Indian subcontinent, excluding the higher levels of 
the Himalayas (Rastogi and Mehrotra, 1998; Shah et al., 2008). MK is widely used 
as a spice and condiment in India and other tropical countries. The leaves, bark and 
the root of this plant are used intensively in indigenous medicine from ancient time, 
as a tonic for stomachache, stimulant and carminative (Pruthi, 1998). MK leaves 
mixed with fat separated butter is used for the treatment of amoebiasis, diabetes and 
hepatitis in Ayurveda (Pillai and Gopala, 1958; Bose and Chandra, 1985; Satyavati 
et al., 1987) and it is traditionally consumed by diabetics in southern part of India 
(Yadav et al., 2002).  
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Withania coagulans Dunal (Family: Solanaceae) is a shrub commonly 
known as Indian cheese maker occurs in dry parts of India. Traditionally the plant is 
used for the control of diabetes mellitus, dyspepsia, flatulent colic and for diuretic 
purpose (Kirthikar and Basu, 1933; Hemalatha et al., 2008). The fruits of this plant 
are used for coagulation of milk and as blood purifier (Ali et al., 2009). Different 
parts of this plant have been reported to possess a variety of biological activities viz. 
antibacterial (Budhiraja et al., 1987; Khan et al., 1993), antifungal (Choudhary et 
al., 1995), anti-inflammatory (Budhiraja et al., 1984), Cardiovascular (Hemalatha et 
al., 2008) and antitumer activity (Chattopadhyay et al., 2007). The plant was also 
reported to have hepatoprotective, antihyperglycaemic, hypolipidaemic, free radical 
scavenging, antimicrobial, central nervous system depressant, antitumour and 
cytotoxic activities (Maurya, 2010).  
Withania somnifera (Family: Solanaceae) is a shrubby xerophytic herb, 
commonly known as Winter cherry or Asgandh. It is cultivated in India, East Asia 
and Africa and can also grow at high altitude up to 5, 500 feet in the Himalayas 
(Uddin et al., 2012). It offers tremendous medicinal properties including 
antibacterial, anti-inflammatory, anti-fungal, antitumor and immune-boosting 
(immunomodulatory) properties (Singh et al., 2010). It has also been reported to 
have beneficial effects in several cases including rheumatoid arthritis, polyarthritis, 
lumbago, painful swellings, spermatorrhoea, asthma, leucoderma, general debility, 
sexual debility, amnesia, anxiety neurosis (Uddin et al., 2012). It helps improve 
vitality and combat insomnia, cancer, arthritis and diabetes. Although its 
immunomodulatory properties are well known, however, its chemotypes still need 
further exploration (Gupta et al., 2003).  
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Aims of Immunostimulation 
 Immunostimulation constitutes an attractive alternative to conventional 
chemotherapy and prophylaxis of infections, especially when the host defense 
mechanisms have to be activated under conditions of impaired immune 
responsiveness (Wagner et al., 1985a). Immunostimulants or immunopotentiators 
are compounds leading predominantly to a nonspecific stimulation of the 
immunological defense system. They do not affect immunological memory cells. 
Therefore the terms immunomodulation or immunoregulation, denoting any effect 
on or change of immune responsiveness, very often seem to be more appropriate. 
Immunoadjunvants are substances that enhance the production of antibodies without 
acting as antigens themselves. Their effects are often thymus-dependent 
Mechanism of Immunostimulation 
Immunological defence is a complicated interplay between nonspecific and 
specific, cellular and humoral immune responses, stimulation and suppression of 
immune competent cells, and the influence of endocrine and other mechanisms upon 
the immune system. Primary targets of the immunostimulant are T or B lymphocytes 
or the complement system, an increase in phagocytosis by macrophages and 
granulocytes plays a central role in immunostimulation (Kuby, 1994). Activation of 
macrophages is probably important for the stimulating agents to remain in contact 
with the reactive cell. The second most important role is the stimulation of T 
lymphocytes, which can be achieved either directly or indirectly, via macrophages 
(Wagner et al., 1985) 
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DNA THERAPY 
 An alternative method of DNA-based immunization that has received 
significant attention recently is the use of CpG-rich (cytosine phosphorothioate-
linked guanosine DNA) immunostimulatory DNA sequences as inhibitors of Th2 
responses to antigen. Interest in this approach began when studies demonstrated that 
the CpG DNA motifs in Mycobacterium bovis BCG DNA induced interferon-Ȗ, a 
cytokine produced by Th1 cells.56 In contrast, the immunostimulatory effect of 
vertebrate DNA is significantly lower than that of bacterial DNA. The reduced 
immunostimulatory effect of vertebrate DNA is probably related to a combination of 
the lower frequency of CpG DNA motifs in vertebrate compared to bacterial DNA, 
as well as a high frequency of cytosine methylation in vertebrate compared to 
bacterial DNA, which abolishes the immunostimulatory effect of vertebrate CpG 
DNA sequences. The DNA hexamer sequences generating the optimal ThL adjuvant 
effect in mice include the motif 5′ - purine–purine–CpG–pyrimidine–pyridimidine-
3′, e.g. AACGTT or GACGTC Which activates the secretion of IFN-Ȗ. CpG DNA 
has an indirect effect on the adaptive immune response by activating the innate 
immune system (e.g., plasmacytoid dendritic cells) to upregulate cytokine 
expression (IL-12, IL-18, IFN-Ȗ, IFN-α, IFN-ȕ), upregulate MHC molecules, and 
upregulate co-stimulatory molecules. These effects on the innate immune system 
lead to a cytokine milieu (IFN-Ȗ+, IL-12+) which biases the T-lymphocyte immune 
response towards a Th1 response to newly encountered antigens. 
Studies have demonstrated an important role for a Toll receptor TLR9 (Toll 
receptor 9)58 in mediating signaling of CpG DNA, as the deletion of genes encoding 
TLR-9 in mice results in mice that are unable to respond to CpG DNA.58 As TLR9 
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in humans is expressed primarily by plasmacytoid dendritic cells and B cells, CpG 
DNA exerts its immunomodulatory effects in humans predominantly through its 
effects on plasmacytoid dendritic cells, which subsequently influence the adaptive 
immune response. Toll-like receptors (expressed on a variety of innate immune 
cells) belong to a family of pattern recognition receptors that are postulated to allow 
the innate immune system to sense different classes of pathogen. 
ANTISENSE OLIGODEOXYNUCLEOTIDE THERAPY 
The goal of antisense oligodeoxynucleotide (ODN) therapy is to selectively 
inhibit the expression of a specific gene product by preventing the translation of 
mRNA into protein68 (Fig. 94.6). Antisense ODN therapy acts by sequence-specific 
hybridization to mRNA, inhibiting the expression of that specific gene product while 
not affecting the expression of other genes. Antisense ODN therapy prevents the 
translation of the RNA message into protein and promotes the degradation of the 
message by ribonucleases. In order for antisense ODNs to be synthesized the coding 
sequence of the gene to be inhibited must be known. Antisense compounds are 
generally about 20 base pairs of oligodeoxynucleotides that have a sequence 
complementary to a portion of the targeted mRNA. The poor stability of 
oligonucleotides in vivo has been improved by modifying the phosphodiester 
backbone to a sulfur-containing phosphorothioate backbone, which enhances the 
stability of oligonucleotides to resist enzymatic degradation. 
CYTOKINE-BASED THERAPY 
Cytokines play a key role in regulating the initiation, perpetuation, and 
resolution of allergic inflammation (Chapter 10). Based on studies demonstrating 
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that several cytokines are expressed in the airway inasthmatics, novel therapeutics 
have been developed to target individual cytokines in patients with asthma to 
determine whether any of these individual cytokines may play an important role in 
disease pathogenesis. 
Pre-clinical studies in animal models of asthma have demonstrated that 
targeting individual cytokines such as TNF, IL-4, or IL-5 reduces levels of 
eosinophilic airway inflammation and airway responsiveness. 
TNF 
To date, the principle that one can target a single cytokine and have a 
significant impact on human disease expression has been best validated in the 
treatment of autoimmune disease such as rheumatoid arthritis (RA) with inhibitors 
of the cytokine TNF-α.79 Currently there are three TNF inhibitors used in clinical 
practice: infliximab (a chimeric monoclonal antibody), etanercept (a soluble TNF 
receptor/Fc fusion protein), and adalimumab (a human monoclonal antibody).79 
TNF inhibitors have also been shown to be highly effective in treating a number of 
other systemic inflammatory autoimmune diseases, including ankylosing 
spondylitis, psoriatic arthritis, psoriasis, and Crohn’s disease. The success of TNF-α 
inhibitors in RA represents a proof-of-concept that inhibition of a single cytokine 
can be effective in treating a disease in which multiple cytokines are expressed, if 
that cytokine serves a key or central role. Most RA patients respond to TNF-α 
inhibitors with a reduction in signs and symptoms, improved quality of life, and 
preservation of functional status.79 Radiographs demonstrate objective evidence 
that TNF-α inhibitors also significantly slow disease progression in RA to an extent 
not seen with any previous agents. Interestingly, although initial experience with 
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TNF inhibitors was most commonly in RA patients with chronic refractory disease, 
more recent studies have demonstrated even better clinical outcomes when TNF 
inhibitors were used earlier in the disease course.80 As TNF inhibitors do not induce 
immunologic tolerance, maintenance of clinical efficacy almost always requires 
continued therapy, certainly for patients with long-standing RA. Importantly, 2–4-
year and longer studies of anti-TNF-α therapy in RA suggest that the clinical 
response is well maintained. Nevertheless, some patients fail to respond to anti-TNF 
therapy and others eventually lose their response. Interestingly, patients failing one 
TNF inhibitor may respond to therapy with another. 
Inhibition of TNF has also been studied in patients with asthma,81–84 
although results have not been as clear cut nor as dramatic in all asthma studies as in 
autoimmune conditions. Examples of studies in asthma which have shown a benefit 
to TNF blockade include studies of the soluble TNF receptor etanercept in 10 
patients with severe asthma, which noted improvements in FEV1, airway 
responsiveness to methacholine, and asthma-related quality of life.81 In another 
study of 38 symptomatic subjects with moderate asthma, infliximab did not 
demonstrate significant clinical efficacy in terms of the primary endpoint of lung 
function. However, there was a significant reduction in the number of moderate 
asthma exacerbations in the infliximab group compared to placebo. It is possible that 
only a subset of severe asthmatics respond to anti-TNF therapy, and that levels of 
expression of membrane-bound TNF-α by peripheral blood monocytes in such 
subjects with asthma may predict responses. 
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IL-4 
IL-4 mediates several important proinflammatory functions in allergic 
inflammation, including induction of the IgE isotype switch, induction of vascular 
cell adhesion molecule-1, promotion of eosinophil transmigration across the 
endothelium, stimulation of mucus production, and promotion of Th2 lymphocyte 
differentiation. The therapeutic potential of a recombinant soluble IL-4 receptor (IL-
4R) as an IL-4 antagonist has been studied in asthmatics. In two small studies, 
treatment with the IL-4 receptor antagonist improved asthma symptom scores and 
pulmonary function, reduced ȕ2-agonist rescue use, as well as lowering levels of 
exhaled nitric oxide. However, subsequently two large phase III studies in 
moderateto- severe asthma failed to reveal efficacy, possibly due to dose limitations 
and the short duration of action of the IL-4 receptor antagonist. 
IL-5 
As IL-5 is a key regulator of eosinophil proliferation, studies have 
investigated whether targeting IL-5 would reduce eosinophilic inflammation and 
improve asthma outcomes. In asthmatics, therapy with an anti-IL-5 
Immunosuppression 
These agents could be used for control of pathological immune response in 
autoimmune diseases, graft rejection, graft versus host disease, hypersensitivity 
immune reaction (immediate or delayed type), and immune pathology associated 
with infections. Out of the list the maximum use of these agents has been for 
prevention of graft rejection and treatment of autoimmune diseases 
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Physical immunosuppression Methods  
Surgical manipulation can have a major impact on immune responsiveness. 
Surgical removal of the bursa, or the thymus, or both in the neonatal period block 
the development of immunologic competence in the correspondingly dependent 
lymphoid system. Surgical removal of these tissues after immunologic development, 
however, has very little effect on immune competence.  
Radiation: acts on the lymphoid cells and bone marrow. Radiation damages 
DNA; thus, cells that are in the process of division or that need to divide to express 
their immunologic role will be most affected by this exposure. It is used in the 
treatment of lymphoid malignancies (i.e. Hodgkins disease) and has been attempted 
in other T-suppressor cell autoimmune disorders. The most common adverse effects 
of TLI are moderate constitutional symptoms including fatigue, anorexia, diarrhea, 
abdominal pain, nausea, weight loss, xerostomia, and herpes zoster (Pamphilon et 
al., 1991)  
Pheresis: Pheresis is the discriminating removal of a specific blood component 
(e.g., platelets, plasma, red blood cells, leukocytes, and lymphocytes). Within hours 
to days, plasmapheresis removes antibodies, immune complexes, hormones, drugs, 
and other plasma-soluble substances. Plasmapheresis is used in the following 
immunologically mediated disorders: hyperviscosity syndromes associated with 
myelomas, mushroom poisoning, theophylline toxicity, Goodpastures syndrome, 
autoimmune hemolytic anemia, myasthenia gravis, and systemic lupus 
erythematosus (Hughes et al., 1997). Plasma exchange is the process of separating 
and removing plasma, then replacing it with either fresh frozen plasma or plasma 
protein fractions. Selective forms of cellular pheresis are used to treat a variety of 
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disorders. For example, plateletpheresis is used for essential ihrombocytosis, 
hemapheresis for sickle cell anemia, and lymphocytopheresis for leukemias 
(Rosenberg et al., 1986). 
Blood transfusion: Transfusions have also altered immune function by 
either improving renal allograft survival or decreasing bone marrow transplant 
engraftment survivals (Blumberg et al., 1990).  
1.9 Immunosuppressive Drug Cyclophosphamide: Cyclophosphamide also 
known as cytophosphane, is a nitrogen mustard alkylating agent from the 
oxazophorines group. Cyclophosphamide has been shown to supress primary and 
secondary humoral immune response, delayed type of hypersenstivity, skin graft 
rejection and animal diseases of autoimmunity (Eric R. Hurd, 1973). It is used to 
treat various types of cancer and some autoimmune disorders. A prodrug, it is 
converted in the liver to active forms that have chemotherapeutic activity. 
Cyclophosphamide also decreases the immune system's response to various diseases 
and conditions. Therefore, it has been used in various non-neoplastic autoimmune 
diseases where disease-modifying antirheumatic drugs (DMARDs) have been 
ineffective (Steinberg et al., 1971). it is also used to treat minimal change disease, 
severe rheumatoid arthritis (Townes et al., 1976), Wegener's granulomatosis 
(Novack and Pearson, 1971), and multiple sclerosis (Makhani et al., 2009)  
Recent clinical studies have shown cyclophosphamide induces beneficial 
immunomodulatory effects in the context of adaptive immunotherapy. Although the 
mechanisms underlying these effects are not fully understood, several mechanisms 
have been suggested based on potential modulation of the host environment, 
including  
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1. Elimination of T regulatory cells (CD4+CD25+T cells) in naive and tumor-
bearing hosts 
2. Induction of T cell growth factors, such as type I IFNs, and  
3. Enhanced grafting of adoptively transferred tumor-reactive effectors T cells 
by the creation of an immunologic space niche.  
Thus, cyclophosphamide preconditioning of recipient hosts (for donor T cells) has 
been used to enhance immunity in naïve hosts, and to enhance adoptive T cell 
immunotherapy regimens, as well as active vaccination strategies, inducing 
objective antitumor immunity. Arnold and Bourseaux (1958) first synthesized 
Cyclophosphamide, which interferes with cell growth only after activation in tissue. 
It is capable of inhibiting both humoral and cell-mediated immune response (Shand 
et al., 1979, Doherty, 1981). 
Azathioprine:  
Azathioprine (IMURAN) is a purine antimetabolite which is used as a first-
line therapy or as an alternative to nitrogen mustard, alkylating agents, for treatment 
of immune-mediated disease. Azathioprine, an imidazole derivative of 6-
mercaptopurine, that acts as an Antimetabolite to inhibit nucleic acid synthesis via 
both de novo and salvage pathways. Rapidly dividing cells, including not only T- 
and B-cell lymphocytes but also, for example, gut endothelium and bone marrow 
elements, are most susceptible to the drug's antiproliferative effects. In addition, it 
has been suggested that the imidazole residue of Azathioprine alkylates thiol groups 
on T-cell surface membranes block antigen recognition. Myelosuppression, 
particularly leukopenia, is the most common and serious side effect of Azathioprine 
therapy (Rossi et al., 1993). It induced hepatotoxicity due to endothelial damage and 
may cause veno-occlusive disease (Sterneck et al., 1991). Other toxicities relate to 
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its antimitotic effects, including alopecia, oral ulcers, nausea, vomiting, diarrhea, 
anorexia and esophagitis. The increased incidence of malignancies with 
Azathioprine tends to be less than that observed with other 
immunosuppressants, probably owing to its modest relative potency 
(Blohme and Brynger, et al., 1985; Rossi et al., 1993). 
Methods for Testing Immunological Factors  
The routine process for screening is to extract single ingredient or single 
distilled fraction from herbal drugs, determine its bioactivity by the classic 
pharmacological means. The whole animal model is the most classic 
pharmacological screening model, which is very important at the aspect of medicine 
evaluation because it can apparently respond to the efficacy, side effect and toxicity 
of medicines in whole. Although this method is high cost and low efficient, at 
present it is still a primary way to drug discovery and evaluation 
In vitro methods:  
1. Inhibition of histamine release from mast cells  
2. Mitogen induced lymphocyte proliferation  
3. Inhibition of T cell proliferation  
4. Chemiluminescence in macrophages  
5. PFC (plaque forming colony) test in vitro  
6. Inhibition of dihydro-orotate dehydrogenase  
In vivo methods:  
1. Spontaneous autoimmune diseases in animals  
2. Acute systemic anaphylaxis in rats  
3. Anti-anaphylactic activity (Schultz-Dale reaction)  
4. Passive cutaneous anaphylaxis  
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5. Arthus type immediate hypersensitivity  
6. Delayed type hypersensitivity  
7. Reversed passive arthus reaction  
8. Adjuvant arthritis in rats  
9. Collagen type II induced arthritis in rats  
10. Proteoglycan-induced progressive polyarthritis in mice  
11. Experimental autoimmune thyroiditis  
12.  Coxsackievirus B3-induced myocarditis  
13.  Porcine cardiac myosin-induced autoimmune myocarditis in rats  
14.  Experimental allergic encephalomyelitis  
15.  Acute graft versus host disease (GVHD) in rats  
16.  Influence on SLE-like disorder in MRL/lpr mice  
17.  Prevention of experimentally induced myasthenia gravis in rats  
18.  Glomerulonephritis induced by antibasement membrane antibody in rats  
19.  Auto-immune uveitis in rats  
20.  Inhibition of allogenic transplant rejection 
AUTOIMMUNITY  
Overactive immune responses comprise the other end of immune 
dysfunction, particularly the autoimmune disorders. Here, the immune system fails 
to properly distinguish between self and non-self, and attacks part of the body. 
Under normal circumstances, many T cells and antibodies react with “self” peptides. 
One of the functions of specialized cells (located in the thymus and bone marrow) is 
to present young lymphocytes with self antigens produced throughout the body and 
to eliminate those cells that recognize self-antigens, preventing autoimmunity. 
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IMMUNOLOGIC EFFECTS 
Inhibition of cell replication may be the key therapeutic mechanism of methotrexate 
in neoplastic conditions. Lymphocytes divide rapidly in the course of the immune 
response, and thus immunosuppression may be one mechanism of action of 
methotrexate in various immunologic diseases. However, several observations have 
suggested that other mechanisms may be relevant in non-malignant conditions. For 
example, in contrast to its use in the treatment of malignancies, the lower doses of 
methotrexate commonly used in rheumatoid arthritis (RA) are infrequently associated 
with myelosuppression or clinical signs of systemic immunosuppression. In 
addition,supplementation with low doses of folic acid may obviate some of the toxicity 
seen in RA patients receiving methotrexate without significantly attenuating its clinical 
efficacy.1,2 In vivo studies have shown that methotrexate can induce various 
immunomodulatory effects, including effects on cellular immunity, humoral immunity, 
and inflammation.1,3,4 Two relevant mechanisms underlie the anti-inflammatory effect 
of methotrexate at the doses typically used in non-malignant conditions: 
(1) Inhibition of the intermediate step in purine metabolism catalyzed by amino-
imidazole-carboxy-amido-ribonucleotide (AICAR) transformylase, leading 
to the increased release of adenosine; and 
(2)  Interference with transmethylation reactions, such as the methylation of 
homocysteine to methionine.1 The precise mechanisms by which AICAR 
inhibition results in increased extracellular concentrations of adenosine 
remain to be defined, but through interactions with specific receptors (A1, 
A2a, A2b, A3) on various cell types, adenosine exerts potent and diverse 
antiinflammatory actions. 
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INTRAVENOUS IMMUNOGLOBULIN 
In healthy individuals, following IVIG infusion there is a biphasic plasma 
IgG disappearance curve, with the initial phase representing distribution between 
body compartments and early catabolism, and the second phase representing 
catabolism.The half-life of IVIG ranges from 14 to 24 days in healthy individuals 
and is more prolonged (26–35 days) in patients with humoral immunodeficiencies. 
IVIG has a variety of immunomodulating properties. Which are of potential benefit 
in immunologically mediated diseases such as immune thrombocytopenic purpura 
and Kawasaki syndrome. These immunologic effects include blockade of Fc 
receptors, anti-cytokine effects, down regulation 
of T- and B-cell function, inhibition of complement activation. enhanced clearance 
of endogenous IgG, anti-idiotype suppression, and neutralization of super 
antigens.30 Which, if any, of these effects may be useful in the treatment of asthma 
or allergy is currently not known.In vitro studies have shown that IVIG inhibits 
cytokine dependent lymphocyte proliferation, as well as cytokine (IL-2, IL-4) 
production by T lymphocytes. 
Immunoglobulin E 
Inhibition of IgE production by B cells is one postulated mechanism by 
which IVIG may exert an immunomodulating effect in asthma.This effect of IVIG is 
postulated to occur through co-ligation of the B cell FcȖ RIIB receptor and the B-
cell antigen receptor, with resultant negative signaling in B cells. IVIG could thus 
provide an off signal to the B cell to inhibit B-cell proliferation and immunoglobulin 
production. In vitro, IVIG inhibits IgE production by B cells. In open-label studies 
IVIG has been shown to reduce the immediate skin reactivity to allergen.Although 
there is some experimental evidence to suggest that 
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IVIG may reduce IgE levels in vivo a reduction in IgE is not noted in the majority of 
studies which have investigated this immunomodulatory property of IVIG. 
Sino pulmonary infections 
IVIG might theoretically improve asthma by reducing the incidence of 
sinopulmonary infections. Evidence for this has not adequately been addressed in 
current studies with IVIG. 
Medicinal values for some of the sources of the used compound 
Few medicinal values of some selected plants are discussed below. Buxus 
Plant species are distributed throughout the world. More than 150 new steroidal 
alkaloids have been isolated from different Buxus species (Naz et al., 1995). 
Extracts of various species have been used to treat rheumatism, malaria, depression, 
skin and veneral diseases in folic medicine (Cordell, 1981, Naz et al., 1995). The 
crude ethanolic extract of the plant is reported to be active against the human 
immunodeficiency Virus (HIV) and other diseases in which the or necrosis factor is 
involved and it has also been reported in the literature that trail dose administration 
of B. sempervirens preparation (SPV30) in HIV-infected asymptomatic patients 
have shown a delay in the progression of HIV disease and no severe side effects 
were observed (Durant et al., 1998). Cyclobuxine-D isolated from B. microphylla 
has shown a hypotensive, anti-inflammatory, and bradycardiac effects and found to 
protect rat heart from the myocardial injuries (Lee et al., 1993). Withania plants e.g. 
W. coagulants and W. somnifera grow widely in India and Pakistan and used in 
indigenous system of medicine. Withania somnifera has been repeatedly shown to 
be a very potent immunomodulatory agent, apart from being anti-tumor, 
hepatoprotective (Ahumada et al., 1991, Bhakuni et al., 1969). Sitoindoside VII, 
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VIII, IX & X isolated from W. somnifera has already been proved for their 
immunomodulatory activities (Bhattacharya et al., 1997). Withanoloids are very 
interesting since many of them show potent antitumor, antibacterial, antifungal, anti-
inflammatory and immunosuppressive activity (Atta-ur-Rahman and Choudhary, 
1999, Devi et al., 1992).  
Corchorus this genus contain about 100 species which are distributed mainly 
in south-East Asia and South America (Chopra et al., 1956). Corchorus deppressus 
L is one of those grow in this region. Leaves are used in folk medicine as an 
emollient and cooling agent. The mucilage of these plants is used for treatment of 
gonorrhoea and applied as a poultice for healing wounds (Perry and Metzgar, 1980). 
The decoction of the seeds and leaves used as a tonic and the infusion is used as a 
drink to relief fever (Whaid and Siddique, 1961) as well it is found to have 
antipyretic antianalgesic activity (Ikram et al., 1987, Vohora et al., 1981). Tephrosla 
purpurea has been shown to possess significant activity against hepatotoxicity, 
pharmacological and physiological disorders. It inhibits benzoyl peroxide-mediated 
cutaneous oxidative stress and toxicity marine skin. Topical application of 
Tephrosia purpurea prior to each application of croton oil (phorbol ester) resulted in 
a significant protection against cutaneous carcinogenesis (Saleem et al., 2001). 
Extracts from these plants have insecticidal, pesticidal, antihelminthic, anticancer, 
and antiulcer activity and are used in traditional medicines (Pirrung et al., 1998). 
Pleleopsis hyiodendron plants of the genus pteleopsis are known to possess medical 
importance. It is used in African countries for treatment of gastric and duodenal 
ulcers (Germano et al., 1998). Vitex agnus castes the Chaste tree berry extracts 
found to inhibit basal as well as TRH-stimulated prolactin secretion of rat pituitary 
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cells in vitro (Sliutz et al., 1993). Most of the activities and medicinal uses of this 
plant is related to female menopause.  
Anogeissus sheimperi this is a small genus of Combretaceae family 
comprising 5 species found in tropical Africa and Asia. Several triterpenoids were 
isolated including oleanolic acid from this plant (Atta-ur-rahman et al., 2003). 
Oleanolic acid compound is quite common in nature and has now become a 
multifaceted of a number of pharmacological activities since it posses' anti-HIV, 
antiviral, anti-inflammatory, sedative, hapato-protective, analgesic, cardiotonic and 
tonic effects (Mengoni et al., 2002, Liu et al., 1995). It has been reported for 
inhibition of or promotion in vitro and in vivo experiments (Ohigashi et al., 1986, 
Wang and Jiang, 1992) and in it is recommended for skin cancer therapy (Oguro et 
al., 1998). 
Table. No. Plants having Immunomodulatory activity 
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2. AIM AND OBJECTIVE 
3.1 General objective   
 To evaluate in vivo immunomodulatory activity of ethanolic extract of 
Annona recticulata. Linn fruits. 
3.2 Specific objective  
 Extraction and characterization of component from ethanolic extracts of 
fruits of Annona recticulata. Linn. 
 To evaluate acute toxicity study of ethanolic extracts of fruits of Annona 
recticulata. Linn 
 To evaluate in vivo immunomodulatory activity of ethanolic extracts of fruits 
of Annona recticulata. Linn by following methods 
o Delayed type hypersensitivity (DTH) response 
o Humoral antibody (HA) titer 
o Total leukocyte count 
o Determination of total serum protein 
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3. PLAN OF WORK 
 Collection and authentification of plant and plant materials 
 Clean and perform size reduction of plant materials 
 Plant material dried in shade and pulverized dried materials 
 To perform the extraction and characterisation of ethanolic extract. 
 To perform preliminary phytochemical studies 
 To evaluate the acute toxicity study of ethanolic extract 
 To evaluate in vivo immunomodulatory activity of ethanolic extracts of 
fruits Annona recticulata. Linn by following methods  
 Delayed type hypersensitivity (DTH) response  
 Humoral antibody (HA) titer  
 Total leukocyte count  
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4. REVIEW OF LITERATURE 
Literature review is the first and most important step for the proper selection 
of plants and it also forms basis for the planning of any scientific work that has to be 
performed. Due to this reason, the review of literature regarding Annona recticulata 
has been done under various divisions like Pharmacognostical, Phytochemical, 
Pharmacological, Ethnomedical and also miscellaneous reviews. 
2.1 Natural Immunomodulators 
Heracleum nepalense (family Apiaceae) exhibited stimulant property and 
increased the rate of respiration and blood pressure in goats (Council of Scientific 
and Industrial Research.The wealth of India: A dictionary of Indian raw material and 
industrial products. New Delhi: Publication and Information Directorate, Council of 
Scientific and Industrial Research). An investigation was undertaken to evaluate the 
immunostimulatory potential of Heracleum nepalense roots by using in vitro and in 
vivo models. The immunostimulatory potential of this plant was investigated by in 
vitro phagocytic index and lymphocyte viability tests, using IFN-a-2b, a known 
immunostimulant drug, as the standard. Other tests such as carbon clearance, 
antibody titer and DTH were studied in mice by using levimasole as the standard. 
The dried root extract (1000 iig/mL) and isolated quercetin glycoside (50 tig/mL) 
significantly increased the in vitro phagocytic index and lymphocyte viability in all 
assays. They also showed a significant increase in antibody titer, carbon clearance 
and DTH in mice. Thus Heracleum nepalense exhibited a dose-dependent 
immunostimulant effect, which could be attributed to the flavonoid content or due to 
the combination with other components (Dash et al., 2006). 
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Actinidia macrosperma (AM) is a medicinal plant in China and has been 
well known for its activities against cancers, especially of lung, liver and digestive 
system. The immunomodulatory effects of AM aqueous extract were examined 
using S180-bearing mice. The immunomodulatory effect was dosedependent in a 
nonlinear fashion with the optimal dose of 100 mg/kg. The AMinduced antitumor 
effects were at least partially indirect and were associated with the modulation of 
immune functions (Lu Y et al., 2007). 
Plumbago zeylanica, commonly known as Doctorbush, is a species of 
plumbago with a pantropical distribution (Family: Plumbaginaceae). Effects of 
seselin identified from Plumbago zeylanica on phytohemagglutinin (PHA) 
stimulated cell proliferation were studied in human peripheral blood mononuclear 
cells (PBMC). The data demonstrated that seselin inhibited PBMC proliferation-
activated with PHA with an IC (50) of 53.87+/-0.74 microM. Cell viability test 
indicated that inhibitory effects of seselin on PBMC proliferation were not through 
direct cytotoxicity. The action mechanisms of seselin may involve the regulation of 
cell cycle progression, interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) 
production in PBMC. Since cell cycle analysis indicated that seselin arrested the cell 
cycle progression of activated PBMC from the G(1) transition to the S phase. 
Seselin suppressed IL-2 and IFN-gamma production in a concentration-dependent 
manner. Furthermore, seselin significantly decreased the IL-2 and IFN-gamma gene 
expression in PHA-activated PBMC. Therefore, results elucidated for the first time 
that seselin is likely an immunomodulatory agent for PBMC (Tsai et al., 2008). 
Withania coagulans (Family Solanaceae) contain six new withanolides, 
withacoagulins A-F (1-6, resp.), together with ten known withanolides, 7-16, were 
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isolated from the aerial parts of Withania coagulans. These compounds, including 
the crude extracts of this herb, exhibited strong inhibitory activities on the T- and B-
cell proliferation. From, that the results showed Withania coagulans has a 
immunosuppressive activity (Huang et al., 2009). 
The immunomodulatory effect of clove, Syzygiurn arornaticurn (Family: 
Myrtaceae) essential oils was evaluated by studying humor- and cell-mediated 
immune responses. Essential oils were administered to mice (once a day, orally, for 
a week) previously immunized with sheep red blood cells (SRBG5). Glove essential 
oil increased the total white blood cell (WBG) count and enhanced the delayed-type 
hypersensitivity (DTH) response in mice. Moreover, it restored cellular and humoral 
immune responses in cyclophosphamide immunosuppressed mice in a dose-
dependent manner. The findings were established that the immunostimulatory 
activity found in mice treated with clove essential oil is due to improvement in 
humor- and cell-mediated immune response mechanisms (Carrasco et al., 2009). 
Aegle marmelos, belongs to family Rutaceae is generally known as bael fruit. 
They were evaluated for potential immunomodulatory activity using the in vitro 
Polymorphonuclear leukocyte function test. Both Methanolic and Ethanolic extract 
of Aegle marmelos leaves were evaluated for their immunomodulatory activity. The 
extract was tested for hypersensitivity and hemagglutination reactions; using sheep 
red blood cells (SRBC) antigen methanol extract exhibited a significant increase in 
the percentage phagocytosis versus the control. The Methanolic extract was found to 
stimulate cell mediated and antibody mediated immune responses in rats (Choubey 
A et al., 2010). 
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To study the immunomodulatory activity of saline extracts of leaves of Aloe 
vera Linn. (Family: Liliaceae) on the albino mice. The saline extract of leaves of 
Aloe vera was administered orally according to their body weight in mice. The 
assessment of immunomodulatory activity on specific and nonspecific immunity 
was studied by administration of test extract. The study demonstrates that A. vera 
triggers both specific and non-specific responses to a greater extent. The study 
comprised the acute toxicity and preliminary phytochemical screening of A. vera. 
From the results obtained and phytochemical studies the immunostimulant effect of 
Aloe vera could be attributed to the alkaloids content (Atul et al., 2011). 
The immunomodulatory activity of an Indian medicinal plant i.e. ethanolic 
extract from Dodonaea viscosa L.F. namely DV was studied for there phagocytic 
activity, cell mediated and humoral immune system on rat/mouse. 
Immunomodulatory effect was assessed in carbon clearance test, delayed type of 
hypersensitivity (DTH), T-cell population test, and sheep erythrocyte agglutination 
test (SEAT) in animal treated with DV at doses of 200 and 400 mg/kg. In carbon 
clearance test, D. viscosa exhibited significantly high phagocytic index against 
control group, indicating stimulation of the reticuloendothelial system. Significant 
decrease in mean difference, in the foot paw thickness in DTH indicates its anti-
inflammatory activity. In SEAT D. viscosa treated groups at 200, 400 mg/kg doses 
showed significant increase in antibody titer against control in normal immune 
status animals while In T-cell population test, showed significant increase in T-cell 
rosette formation against control. These results confirm the immunomodulatory 
activity of D. viscosa extract, which is a known immunomodulator in indigenous 
medicine (Jagdap et al., 2011). 
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2.2 Annona recticulata  
 Rasika Dnyandeo Bhalke, Machindra Jayram Chavan, to evaluate possible 
effects of various extracts of Annona reticulata bark on CNS. Petroleum ether, ethyl 
acetate and methanol extracts of the bark of Annona reticulata L. (Annonaceae) 
were evaluated for analgesic and CNS depressant activities in different animal 
models. All the extracts exhibited significant central analgesic activity in the hot 
plate method in mice. All the extract showed statistically significant mild to 
moderate central nervous system depressant activity assessed by locomotors activity 
assay and pentobarbitone sleeping time test (Mahindra Jayram Chavan et al., 
2011) 
Jani switu, Harish C R, Mohaddesi Behzad, compared Pharmacognostical 
study of Annona squamosa and Annona recticulate leaves belongs to the family 
Annonaceae. Pharmacognostical study of Annona squamosa showed lysogenous 
cavity and spars trichomes where as A.recticulata showed multicellular trichomes 
filled with tannins and stone cells. The powder charectoristics of A.squamosa 
showed stone cells and prismatic crystals of calcium oxalate where as A.recticulata 
showed pitted stone cells and micro rosettes crystals of calcium oxalate. Annular 
vessels, lysogenous cavity and paracytic stomata are the common charecters 
observed  in both leaves (Jani switu et al., 2012) 
Tran Dinh Thang, Ping-Chung Kuo, Guan-Jhong Huang, Nguyen Huy Hung, 
Bow-Shin Huang, Mei-Lin Yang, Ngo Xuan Luong and Tian-Shung Wu, to the 
chemical investigation of the leaves of Annona reticulata has resulted in the 
identification of nine compounds, including annonaretin A, a new triterpenoids. The 
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purified compounds were subjected to the examination of their effects on NO 
inhibition in LPS-activated mouse peritoneal macrophages and most of them 
exhibited significant NO inhibition, with IC50 values in the range of 48.6 ± 1.2 and 
99.8 ± 0.4 μM (Tian-Shung Wu et al., 2013) 
Vishal Kumar Soni, Manisha Pathak, Dinesh Kumar Yadav, Rakesh Maurya,  
Mahendra Sahai, Swatantra Kumar Jain and  Shailja Misra-Bhattacharya, reported 
that  twig of A.recticulata contain a large number of alkaloids, we chose to study its 
medicinal properties on the immune response in mice. The present study, thus, aims 
at evaluation of immunomodulatory activity in the crude ethanolic extract and its 
four fractions, viz. hexane (F1), chloroform (F2), n-butanol (F3) and aqueous (F4) 
prepared from the twigs of AS to locate the active constituents in the fractions. The 
extract and fractions were fed orally at 3, 10 and 30 mg/kg for 14 consecutive days 
and mice were euthanized to assess various immune parameters. The ethanolic 
extract and its three fractions F2, F3 and F4 were found active since they increased 
splenic T and B cellular proliferation with a significant accentuation in peritoneal 
macrophage function, differentially increased the CD4+, CD8+ T lymphocytes and 
CD19+ B lymphocytes. The extract and its active fractions also demonstrated 
significant Th1 or Th2 mixed cytokine response at almost all doses tried in a dose-
dependent manner. Its hexane fraction, however, could only induce reactive oxygen 
species production in peritoneal macrophages and could not induce lymphocytes; 
thus, it remained inactive. Thus, the activity could be localized distributed in its 
three fractions (chloroform, n-butanol and aqueous). Further purification and 
evaluation of the active molecule/s is underway in our laboratory. (Shailja Misra-
Bhattacharya et al., 2013) 
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Kalyani Pathak, Kamaruz Zaman, reported that medicinal importance of 
whole plants of Annona reticulata linn is a highly apparent plant in ayurvedic 
system of medicine for the treatment of various ailments. The plant is traditionally 
used for the treatment of epilepsy, dysentery, cardiac problems, worm infestation, 
constipation, haemorrhage, antibacterial infection, dysuria, fever, ulcer etc. It also 
has antifertility, antitumour and abortifacient properties. This plant is reputed to 
possess varied medicinal properties. Several research workers investigated the 
pharmacological activities of different parts of the plant. Present review gives an 
overview on botanical description, ethnomedical and therapeutic importance and 
chemical constituents (Kalyani Pathak et al., 2013) 
C.A. Gonçalves, N.L. Silva, M.O. Mauro, N. David, A.L. Cunha-Laura, S.A. 
Auharek, A.C.D. Monreal, M.C. Vieira, D.B. Silva, F.J.L. Santos, J.M. Siqueira and 
R.J. Oliveira, Evaluate mutagenic, teratogenic, and immunomodulatory effects of 
Annona nutans hydromethanolic fraction on pregnant mice. To analyze the potential 
toxic effects of medicinal plants during gestation. The present study aimed to 
evaluate the effects of A. nutans hydromethanolic fraction leaves (ANHMF) on 
mutagenic and immunomodulatory activity, reproductive performance, and embryo-
fetal development in pregnant female mice. The animals (N = 50 female and 25 
male) were divided into 5 groups: Control, Pre-treatment, Organogenesis, 
Gestational, and Pre+Gestational. The results indicate that ANHMF mainly contains 
flavonoid and other phenolic derivatives. It was found that it does not exhibit any 
mutagenic or immunomodulatory activity and it does not cause embryo-fetal 
toxicity. Based on the protocols used in the present studies, our analyses confirm 
that it is safe to use ANHMF during pregnancy (R.J. Oliveira et al., 2014) 
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Balu Selvakumar, Gokulakrishnan J, Elanchezhiyan K and Deepa J, reported 
that leaves of A.recticulata showed mosquito larvicidal, ovicidal and pupicidal 
activities on Anopheles stephensiliston and culex quinquefasciatus. A. reticulata 
benzene, chloroform, ethyl acetate and methanol extract were tested against 3rd 
instar larvae of Ae. aegypti, An. stephensi and C. quinquefasciatus for 24 hr and 
mortality were recorded at various concentrations. The LC50 and LC90 values were 
determined following probit analysis. The ovicidal activity was determined against 
Aedes aegypti, Anopheles stephensi and Culexquinquefasciatus exposed to various 
concentrations were tested under laboratory conditions. The LC50 and LC90 values 
of benzene, chloroform, ethyl acetate and methanol extract of A. reticulata against 
early third instar larvae of Ae. Aegypti, An. stephensi and Cx. Quinquefasciatus. 
Methanol extracts showed maximum ovicidal activity followed by benzene, 
chloroform and ethyl acetate against selected vector mosquitoes. In pupicidal 
activity, among the four solvent extracts tested against selected mosquitoes at 
200ppm higher concentrations, the methanol was found to be most effective for 
pupicidal activity provided against C. quinquefasciatus, Ae. aegypti and An. 
stephensi respectively. The present investigation lead the path of exploration of 
Annona reticulata for eradication of selected medically important human vector 
mosquitoes, thereby, gaining a real momentum to include this plant product for 
intense vector control programme (BaluSelvakumar et al., 2015)  
 Lauve Rachel Tchokouaha Yamthe, Patrick Valere Tsouh Fokou, Cedric 
Derick Jiatsa Mbouna, Fabrice Fekam Boyom, reported that antimalarial activity of 
ethanolic extract of Annona muricata and Annona recticulata. Cytotoxicity studies 
on erythrocytes and Human Foreskin Fibroblasts cells and against the W2 strain of 
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P. falciparum in culture. IC50 values of extract ranging from 0.07 to 3.46 µg/mL. 
The most potent was the subfraction 30 from A. muricata stem bark (IC50 = 0.07 
µg/mL) with a selectivity index of ˃ 142. Subfraction 3 from A. muricata root also 
exhibited very good activity (IC50 = 0.09 µg/mL) with a high selectivity index (SI ˃ 
111). Amongst the isolated compounds, only gallic acid showed activity with IC50 
of 3.32 µg/mL and SI > 10. These results support traditional claims for A. muricata 
and A. reticulata in the treatment of malaria (Fabrice Fekam Boyom et al., 2015) 
 Ruchi. N. desai, pankaj. K. hiradhar, to reported that larvicidal activity of 
methanolic extract of leaves of Annona recticulata, active against a limited number 
of species including specific target insects, less expensive, easily biodegradable to 
non-toxic products, and potentially suitable for use in mosquito control programme. 
The present study clearly suggests the efficacy of A. reticulata extract on larvae of 
C. quiquefasciatus. Thus there are all chances of exploring this plant for its 
pupicidal, antifeedent, adulticidal, mode of action, synergism with the biocides 
under field condition and various other aspects which can be commercially used 
instead of the synthetic chemicals found in the market which are tremendously 
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5. PLANT PROFILE 
         
                              Fig. 4  Whole Plant                             Fig. 5 Fruits 
Scientific Classification 
Domain : Eukaryota  
Kingdom : Plantae  
Class  :  Angiosperms  
Division  :  Magnolids  
Order  : Magnoliales  
Family : Annonaceae  
Genus : Annona  
Species : Reticulata  
Botanical name : Annona retiulata  
Common names : Custard apple 
Synonyms  
Shubha, Sitaphala, Annona excelsa Kunt,  Annona laevis Kunth, .Annona 
longifolia Moc,  Annona longifolia Sesse, Annona riparia kunth. 
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Vernacular Names  
English : Custard apple, wild sweet sop  
Hindi  : Ramaphal  
Telugu  : Ramaphalamu  
Assamese  : Atlas,Ata  
Gujrat  : Sitaphal  
Punjub  : Sharifa  
Oriya  : Ato   
5.1 Botanical Description   
A tree about 6m high. Bark thin and grey. Leaves simple, alternate, 3.5-8 
x1.5-4 cm, oblong – lanceolate or elliptic, obtuse or subacute, pellucidpunctate, 
glabrous above, glaucous and pubescent beneath when young; lateral nerves 8-11 
pairs, petiole upto 2 cm long. Flower bisexual, drooping, green, solitary, leaf 
opposed or 2-4 on short extra axillary branchlets. Fruit globose, 5-10 cm in 
diameter, usually with a glucose bloom on the surface when young, yellowish-green 
when ripe, easily broken into large pieces; areoles well marked, pulp white, sweet. 
Many seeds, arilate, brownish-black, smooth or polished and hard. (Kamaruz 
Zaman et al., 2013). 
Flowering: March – July  
Fruiting: August –January 
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5.2 Distribution 
It is found wildly and cultivated throughout India upto an altitude of 900m. It 
is found growing gregariously and widely in the hilly tracts, waste lands and has 
become completely naturalized in several districts of Andhra Pradesh, Punjab, 
Rajasthan, Uttar Pradesh, Madhya Pradesh, Bihar, West Bengal, Assam, Gujarat, 
Maharashtra, Karnataka, Kerala and Tamil Nadu. It is a native of South America and 
West Indies. 
5.3 Medicinal Uses 
Annona reticulata is a highly apparent plant in ayurvedic system of medicine 
for the treatment of various ailments. The plant is traditionally used for the treatment 
of epilepsy, dysentery, cardiac problems, worm infestation, constipation, 
haemorrhage, antibacterial infection, dysuria, fever, and ulcer. It also has 
antifertility, antitumour and abortifacient properties (Surendra et al., 2013). 
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6. MATERIALS AND METHODS 
Collection of Materials, Chemicals and Drugs 
 The Sheep Red Blood Cells (SRBCs) were procured from Veterinary College 
Hebbal (KVAFSU), Bangalore. 
 The Levamisole (Cipla Limited- India) was purchased from local pharmacy, 
Bangalore. 
 The Humoral antibody tests were performed in SAROJ diagnostic 
laboratories. All chemicals were procured from SAROJ diagnostic 
laboratories, Calicut. 
Collection and Authentication of Annona Reticulata Fruits  
 Date of collection: 23- 01- 2016. 
 Place of collection: Feroke, Kozhikode dist, Kerala. 
 Time of collection: Early morning hours (6 - 8 am).  
Fruits of Annona reticulata were collected from Feroke Kozhikode. The plant 
material was taxonomically identified by botanist Mr. A. K Pradeep kumar, 
Assistant Professor, Department of Botany, University of Calicut The drug material 
was dried under shade for about 14 days, powdered and stored in an air tight 
container. 
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PHYSICOCHEMICAL EVALUATION OF THE CRUDE DRUG (IP 2006) 
a) Evaluation of foreign matter  
A quantity of 50g of fruits to be examined was weighed and it was spread 
out in a thin layer. The foreign matter was detected by inspection with the nacked 
eye. It was separated and weighed and percentage of foreign matter was calculated. 
b) Moisture content (loss on drying) 
fresh fruits of Annona recticulata was weighed and dried in a hot air oven at 
100°C until a constant weight was obtained. The loss in weight was recorded as 
moisture content. 
ASH VALUE (Kokate et al, 1985) 
Principle 
The ash content of a crude drug is generally taken to be the residue 
remaining after incineration. It usually represents the inorganic salts naturally 
occurring in the drug and adhering to it, but it may also include inorganic matter 
added for the purpose of adulteration. There is a considerable difference varies 
within narrow limits in the case of the same individual drug. Hence an ash 
determination furnishes a basis for judging the identity and cleanliness of a drug and 
gives information relative to its adulteration with inorganic matter. Ash standards 
have been established for a number of official drugs. Usually these standards get a 
maximum limit on the total ash or on the acid insoluble ash permitted. 
The total ash is the residue remaining after incineration. The acid insoluble 
ash is the part of the total ash which is insoluble in diluted hydrochloric acid. 
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The ash or residue yielded by an organic chemical compound is as a rule, a 
measure of the amount of inorganic matters present as impurity. In most cases, the 
inorganic matter is present in small amounts which are difficult to remove in the 
purification process and which are not objectionable if only traces are present. Ash 
values are helpful in determining the quality and purity of the crude drugs in powder 
form. 
Procedures given in Indian pharmacopoeia were used to determine the 
different ash values such as total ash and acid insoluble ash. 
Total Ash 
Weighed accurately about 3 gm of dried powdered drug was taken in a tarred 
silica crucible and incinerated by gradually increasing the temperature to make it 
dull red until free from carbon cooled and weighted and then calculated the 
percentage of total ash with reference to the air dried drug. 
 Acid Insoluble Ash 
The ash obtained as directed under total ash above was boiled with 25 ml of 
2N HCl for 5 minutes. The insoluble matter was collected on ash less filter paper, 
washed with hot water ignited and weighed, then calculated the percentage of acid 
insoluble ash with reference to the air dried drug. 
Water Soluble Ash 
The total ash obtained was boiled with 25 ml of water for 5 minutes. The 
insoluble matter was collected on an ash less filter paper, washed with hot water and 
ignited for 15 minutes at a temperature not exceeding 450˚C. The weight of 
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insoluble matter was subtracted from the weight of total ash. The difference in 
weight represents the water soluble ash. The percentage of water soluble ash 
calculated with reference to the air dried drug. 
   Extractive Values  
Extractive values of crude drugs are useful for their evaluation, especially 
when the constituents of a drug cannot be readily estimated by any other means. 
Further, these values indicate the nature of the constituents present in a crude drug. 
Determination of Alcohol Soluble Extractive Value 
5 gm of the air-dried coarse powder of Annona recticulata  was macerated 
with 100 ml of 90% ethanol in a closed flask for 24 hours, shaking frequently during 
the first 6 hours and allowing standing for 18hours. Thereafter, it was filtered 
rapidly taking precautions against the loss of the solvent. Out of that filtrate, 25 ml 
of the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish, dried 
at 105˚C and weighed. The percentage of ethanol soluble extractive value was 
calculated with reference to the air- dried drug. 
Determination of Water Soluble Extractive Value 
Weigh accurately 5 gm of coarsely powdered drug and macerate it with 100 
ml of water in a closed flask for 24 hours, shaking frequently during the first 6 hours 
and allow to standing for 18 hours. Thereafter, it was filtered rapidly. Then 25 ml of 
the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish, dried at 
105˚C and weighed. The percentage of water soluble extractive was calculated with 
reference to the air dried drug. 
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6.1 Extraction 
Extraction is the separation of medicinally active portions of plant tissues 
using selective solvents through standard procedures. Such extraction techniques 
separate the soluble plant metabolites and leave behind the insoluble cellular marc. 
The products so obtained from plants are relatively complex mixtures of 
metabolites, in liquid or semisolid state or (after removing the solvent) in dry 
powder form. The general techniques of medicinal plant extraction include 
maceration, infusion, percolation, digestion, decoction, hot continuous extraction 
(Soxhlet), aqueous-alcoholic extraction by fermentation, counter-current extraction, 
microwave assisted extraction, ultrasound extraction (sonication), supercritical fluid 
extraction, and phytonic extraction (with hydrofluorocarbon solvents) (Prashant et 
al., 2011). 
Soxhlet ExtractionIn this method, the finely ground crude drug is placed in 
a porous bag or “thimble” made of strong filter paper, which is placed in the middle 
chamber of the Soxhlet apparatus. The solvent taken in the round bottom flask is 
heated, and its vapours get condensed in the condenser. The condensed solvent drips 
into the thimble containing the crude drug, and extracts it by contact. When the level 
of liquid in middle chamber rises to the top of siphon tube, the liquid contents of 
chamber siphon back into round bottom flask. This process is continuous and is 
carried out till extraction is complete. The advantage of this method, compared to 
previously described methods, is that large amounts of drug can be extracted with a 
much smaller quantity of solvent. This affects tremendous economy in terms of 
time, energy and consequently financial inputs. At small scale, it is employed as a 
batch process only, but it becomes much more economical and viable when 
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converted into a continuous extraction procedure on medium or large scale (Handa, 
2008). 
6.2 PHYTOCHEMICAL SCREENING 
Phytochemical screening includes the following steps 
 Preliminary Phytochemical screening 
 Chromatographic and spectroscopic studies. 
 Estimation of total Flavanoids and Phenolic contents. 
Preliminary Phytochemical screening 
Qualitative analysis for determining the presence of alkaloids, tannins, 
Flavanoids, terpenoids , steroids, glycosides, saponins, resin, and oil in the plant 
extracts, were carried out using standard methods as described by Harborne (1973), 
Trease and Evans (1978) and Sofowora (1993). 0.5 gm of the dried extracts were 
dissolved in 20 ml distilled water, filtered and used for various qualitative tests. The 
following chemical testes were carried out using extracts of Curcuma aeruginosa 
rhizome extracts. (Khandelwal, 1998; Kokate, 1993). 
Chemical test for alkaloids 
The extracts were evaporated and to the residue dilute hydrochloric acid was 
added and filtered. With the filtrate, the following tests were performed 
a)  Mayer’s Test  
To 2-3 ml of extract, added few drops of Mayer’s reagent. The formation of 
white or creamy precipitate indicates the presence of alkaloids.  
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b)  Wagner’s Test   
          To 2-3 ml of the extract, added few drops of Wagner’s reagent. Formation of 
reddish      brown precipitate indicates the presence of alkaloids.  
c)  Hager’s Test  
To 2-3 ml of extract, added few drops of Hager’s reagent. A prominent 
yellow precipitate indicates the presence of alkaloids.  
d)   Dragendorff’s Test  
To 2-3 ml of extract, added few drops of Dragendorff’s reagent. A prominent 
orange brown precipitate confirms the presence of alkaloids. 
Chemical tests for glycosides  
a) Legal’s Test  
To the extract, added 1 ml of pyridine and 1 ml of sodium nitroprusside. A 
pink to red colour indicates the presence of glycosides.  
b) Baljet’s Test  
To a few ml of the extract, add 1 ml sodium picrate solution. Yellow to 
orange colour reveals the presence of cardiac glycosides.  
Chemical tests for phenolics  
a) Ferric chloride test  
To 2-3 ml of the extract, add 5% ferric chloride, formation of deep blue-
black colour indicates the presence of phenolic compounds. 
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b) Lead acetate test  
To small quantity of extract, added 3 ml of 10% lead acetate solution was 
added to it. A bulky white precipitate indicates the presence of phenolic 
compounds. 
Chemical tests for flavonoids  
a) Aqueous sodium hydroxide test  
To the residue, addition of increasing amount of sodium hydroxide shows 
yellow colouration, which decolourises after addition of acid indicates the 
presence of flavonoids.  
b) Shinoda test  
To the extract, added 5 ml of 95% ethanol, few drops of concentrated 
hydrochloric acid and 0.5 g of magnesium turnings. The presence of pink 
colour indicates the presence of flavonoids. 
Chemical tests for carbohydrates  
a) Molisch’s Test  
To 2-3 ml of extract added few drops of alpha-naphthol solution in alcohol, 
shaken and added conc. sulphuric acid from the sides of the test tube. A 
violet ring is formed at the junction of two liquids indicates the presence of 
carbohydrates. 
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b) Fehling’s Test  
1 ml of Fehling’s A and 1 ml of Fehling’s B solutions was mixed and boiled 
for one minute. Added equal volume of test solution and heated in boiling 
water bath for 5-10 min. First a yellow, then brick red precipitate is 
observed, indicates the presence of reducing sugars. 
c) Benedict’s Test  
Equal volume of Benedict’s reagent and test solution were mixed, heated in 
boiling water bath for 5 min. Solution appears green, yellow and red 
depending on amount of reducing sugar present in test solution. 
Chemical tests for proteins and amino acids  
a) Millon’s Test  
3 ml of test solution was mixed with 5 ml millon’s reagent. White precipitate 
form and upon warming precipitate turns brick red or the precipitate 
dissolves giving red coloured solution indicates the presence of proteins.  
b) Biuret Test  
3 ml of the test solution was added to 4% sodium hydroxide and few drops 
of 1% copper sulphate solution. Appearance of violet of pink colour 
indicates the presence of proteins.  
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c) Ninhydrin Test  
3 ml of the test solution was heated with 3 drops of 5% Ninhydrin solution in 
boiling water bath for 10 min. Appearance of purple or bluish colour 
indicates the presence of amino acids. 
Chemical test for terpenoids  
3 ml of the extract was added to 2 ml of chloroform. Then 3 ml of 
concentrated sulphuric acid was added carefully to form a layer. A reddish 
brown coloration at the interface indicates the presence of terpenoids. 
Chemical Tests for Steroids  
a)  L ibbermann - Burchard’s Test  
2 ml of the extract was mixed with chloroform, added 1-2 ml of acetic 
anhydride and 2 drops of conc. Sulphuric acid from the sides of the test tube. 
Appearance of first red, then blue and finally green colour indicates the presence of 
steroids.  
b) Salkowski Test  
2 ml of the extract was mixed with 2 ml chloroform and 2 ml concentrated 
sulphuric acid, shaken. The appearance of red colour on chloroform and greenish 
yellow fluorescence on acid layers indicate the presence of steroids. 
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Chemical Tests For Saponins  
a) Foam or Froth Test  
1 ml of the extracts were diluted with water to 20 ml and shaken in a 
graduated cylinder for 15 minutes. One centimetre layer of foam indicates the 
presence of saponins.   
Chemical Test for Sterols   
 Libermann-Burchard test: Mix 2ml of extract with few drops of 
chloroform and acetic anhydride and 2 drop sulphuric acid along the side of 
test tube first blue then red finally green colour appears. 
 Salkowski’s test:  2ml of extract were treated in 2ml chloroform and 2ml 
of concentrated sulphuric acid, shaken well and red colour appeared in 
chloroform layer and greenish yellow fluorescence in acidic layer. 
 Chemical Test for Terpenoids: Extract added with chloroform then adds 
4ml of conc: sulphuric acid carefully to form a layer. Reddish brown 
coloration at the interface shows the presence of terpenoids. 
6.3 Acute Toxicity Study 
Acute toxicity for ethanolic extract of fruits will be done according to the 
office of pollution prevention and toxics (OPPT) The overnight fasted rat is weighed 
and selected. The extracts will be dosed in a stepwise procedure, by using up and 
down or stair case method. The two animals selected with a dose of 50 mg/kg. 
Orally and examined for 24h for mortality. Subsequent dose are then increased to 
attain maximum non lethal and minimum lethal dose. The extract was found to be 
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safe at the dose of 5g/kg per oral. Maximum safe dose (5g/kg) corresponding to 500 
mg/kg and 100 mg/kg were selected as high and low doses respectively. 
Experimental Animals  
The experiment was carried out by using Wistar rats, which were procured 
from central animal house of the Institute. The experimental protocol has been 
approved by institutional animal ethical committee, Komarapalayam. Rats of Wistar 
strain weighing between 150 to 200 gm were maintained under standard laboratory 
conditions. They were provided with a standard diet supplied by Pranav agro 
industries Ltd India. 
Experimental Protocol 
24 rates were divided in to four groups 
Group : Control (normal saline) 
Group II : Annona recticulata ethanolic extract was administered at a dose 100  
  mg/kg/day by oral route 
Group III  : Annona recticulata ethanolic extract was administered at a dose 500  
  mg/kg/day by oral route 
Group IV : Standard- Levamisole was administered at a dose of 50mg/kg/day by    
  oral route for 14 days. 
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6.4 Experimental Setup 
The animal model is required to study the following methods 
 Delayed type hypersensitivity (DTH) response  
 Humoral antibody (HA) titer  
 Total leukocyte count  
 Determination of total serum protein and albumin -globulin ratio 
6.4.1 Delayed Type Hypersensitivity (DTH) Response 
For the evaluation of delayed type of hypersensitivity (DTH) test animals 
were divided in to four groups, having six animals in each. Group I, the control, was 
given 2ml of 5% normal saline and to group II.III, IV was administered of 100 mg 
and 500 mg/kg body weight of ethanolic extract intraperitonially for ten days.  On 
10th day 0.1ml of SRBC solution was injected subcutaneously in to the right 
footpad. After 24,48,72,96 hrs, thickness of footpad was measured by plethisometer. 
Difference in the footpad thickness in control and treated group has been taken as 
the measure of the DTH reaction (Dikshit et al., 2000) 
6.4.2 Humoral Antibody Titre 
The animals were immunized by injecting 0.1 ml of SRBCs suspension, 
containing 1X 10 8 cells, intraperitonially, on day 0. Blood samples were collected 
in micro centrifuge tubes from individual animals of all the groups by retro orbital 
vein puncture on day 10. The blood samples were centrifuged and the serum 
separated. Antibody levels were determined by the hemagglutination technique. 
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Method for Serial dilution 
This was performed by using 96 wells (12x8) U bottomed titre plate. The 
wells were marked from I to XII. In the first (I) and last well (XII) 25 microliter of 
serum collected from treated animals was added and inactivated at 56 degree Celsius 
for 30 minutes. Afterwards to all the wells except well number XII, 25 microliter of 
PBS was added.25 microliter was taken from first well and added to 2nd well again 
25 microliter from second well was taken and added to third well and continued the 
same procedure up to well number XI. After this 25 microliter of sample from well 
number XI was discarded. Finally 25 microliter of 1% SRBC was added to all the 
wells and was kept at room temperature for two hours (Vinod S Pawar et al., 2012) 
6.4.3 Total Leukocyte Count 
 W.B.C diluting pipette: It has got three graduations. Two graduations 0.5 
and 1 are present on the stem of the pipette and the third mark 11 is placed just 
above the bulb. Blood is drawn up to mark 0.5 and the rest of the bulb is filled by 
sucking up diluting solution up to the mark 11, the bulb of the pipette is so 
constructed that it holds exactly 20 times the volume of fluid contained in the stem 
of the pipette up to mark 1.Although fluid is drawn up to 11, the dilution of the 
blood will be 20 because the last part of the fluid remains locked up in the stem and 
is not available for dilution 
The Counting Chamber 
The ruling area consists of 9 square millimeters. The central of the smallest 
squares are separated by triple lines in which RBC will be counted. The side of each 
square for counting WBC is ¼ mm.  
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Diluting Fluid for WBC (Turks fluid)  
Commonly the fluid is made up as follows 
Glacial acetic acid    :  1.5ml   
1%solution of gentian violet in water  :   1ml   
Distilled water    :   98ml  
The glacial acetic acid haemolysis the red cells, while the gentian violet stains the 
nucleus of leukocytes   
Method of Counting W.B.C  
The white cells are counted in four corners of 1 square millimeter ruled area 
on both sides. The white cells are recognized by the retractile appearance and by the 
slight color given to them by the stain contained in the diluting fluid. The cells 
touching the left side and upper side of boundary line are not counted 
Calculations 
The area of the smallest = 1/16 mm3square  
Volume of smallest square      = 1/160 mm3  
Total number of square counted   = 16×4=64  
Total number of cells counted     =      X   
64/160 mm3 of diluted blood contains =     X cells  
So, 1 mm3 of diluted blood contains    =      160/64 × X cells  
1 mm3 of undiluted blood contains    =      160/64 × 20 × X cells. 
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6.4.4 Determination of Total Serum Protein 
Total Protein (Biuret Method) 
Total Protein-To exactly 4 cc. of 10 per cent sodium hydroxide in a 10 ml 
standard flask and add 0.1 cc. of fresh serum with a Folin micropipette. Rinse out 
the pipette three times with sodium hydroxide solution. Mix by rotating and add 0.5 
cc. of 1 per cent copper sulphate. Shake vigorously five to six times. Allow to stand 
for 25 minutes and absorbance read in a U.V Spectrophotometer at 540 nm. 
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7. RESULTS 
7.1 PHYSICOCHEMICAL EVALUATION OF THE DRUG 
Evaluation of foreign matter 
 Foreign matter of fresh fruits of Annona recticulata was found to be 9.82. 
Moisture content (Loss on drying)  
Moisture content of fresh fruits of Annona recticulata was found to be 53.1 
Extractive value  
 Water soluble extract - 7.83% 
 Alcohol soluble extract - 6.37% 
Ash value of the drug 
 Total ash   - 5.8% 
 Acid insoluble ash  - 0.61% 
 Water soluble ash  - 3.71% 
7.2 Phytochemical Screening 
 In preliminary phytochemical analysis was done on the basis of standard 
procedure. Show presence of secondary metabolites. They were shown in table no.1 
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Table. 1. Preliminary phytochemical screening of ethanolic extract of Annona 
recticulata fruits. 
Sl.no Phytoconstituents Ethanolic extract 
1 Alkaloids + 
2 Glycosides - 
3 Flavanoids + 
4 Phenols + 
5 Saponins + 
6 Steroid - 
7 Tannins - 
8 Terpenoids + 
9 Carbohydrates + 
 
7.2 Acute toxicity study 
 For toxicity studies, crude ethanolic extract were administered orally to the 
three groups having two rats in each with graded doses (50mg/kg-500mg/kg body 
weight) of Annona recticulata. Mortality rates were observed after 7 days 
(Choudhary et al., 1997) 
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Table: 2 Determination of acute toxicity of ethanolic extract of Annona 
recticulata 
Sl. No Dose (mg/kg. Body weight) Percent mortality 
1 50 0 
2 100 0 
3 150 0 
4 200 0 
5 250 0 
6 300 0 
7 350 0 
8 400 0 
9 450 0 
10 500 0 
  
7.3 Determination of Delayed Type Hypersensitivity Response 
                 The effect of test extract and standard drugs on the DTH response in 
wistar rats using SRBCs as antigen, administration of ethanolic extract of Annona 
recticulata at the dose of 100mg/Kg and 500mg/Kg and Levamisole 50mg/Kg 
treatments which were given orally. After 24, 48, 72, 96 hrs showed significant 
increase in paw edema compared to control group. 
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Table.3 Effect of crude ethanolic extract of Annona recticulata on delayed type 
of hypersensitivity response 
Sl. 
No 
Groups Paw volume  (mm) 
24 Hrs 48 Hrs 72 Hrs 96 Hrs 
I Control 1.43±0.027 0.72±0.019 0.41±0.013 0.16±0.012 
II Crude ethanolic 
extract (100 mg/kg 
body weight ) 
1.50±0.011 0.88±0.018 0.51±0.015 0.20±0.021* 
III Crude ethanolic 
extract (500 mg/kg 
body weight ) 
1.54±0.016 0.93±0.019 0.57±0.012 0.23±0.014** 
IV Standard – 
Levamisole 
(50 mg/kg body 
weight) 
1.58±0.010 1.02±0.029 0.65±0.021 0.32±0.016*** 
n= 6. Tabulation values represents mean ± SD (*P<0.05, **P<0.025, ***P<0.001 
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Fig. 7 Paw edema observed in animals after injecting sheep’s RBC 
   
 Control animal Annona recticulata 100 mg/kg 
  
 Annona recticulata 500 mg/kg. Levamisole 50 mg/kg 
7.4 Humoral Antibody Titre 
                Administration of ethanolic extract of at the dose of (100 & 500 mg/kg) 
and Levamisole 50mg/Kg treatments which were given orally for 14 days showed 
highly significant increase in antibody titre values compared to control group. The 
results are shown in below table 4 
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Table.4 Effect of crude ethanolic extract of Annona recticulata of Humoral 
Antibody titre   
Sl. No Group Humoral antibody titre 
I Control 11±1.0210 
II Annona recticulata 100 mg/kg body weight 337.47±2.0401* 
III Annona recticulata 500 mg/kg body weight 412±1.5010** 
IV Levamisole 50 mg/kg 461± 2.6861*** 
 
n=6, humoral antibody titre value mean ± SEM (*P<0.05, **P<0.01, ***P<0.001 
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Fig. 9 Button formation of Antibody titre on Microtitre plate 
  
 Control Annona recticulata 100 mg/kg 
  
 Annona recticulata 500 mg/kg Levamisole 50 mg/kg 
7.5 Total Leukocyte Count 
                The effect of test extract and standard drugs on Total Leukocytes in wistar 
rats, administration of ethanolic extract of Annona recticulata at the dose of 
(100,500 mg/kg) and Levamisole 50mg/Kg treatments which were given orally for 
14 days. The low dose of extract (100 mg/kg) show effect on TLC count compared 
to control group, whereas the 500mg/Kg and standard drug Levamisole 50mg/Kg 
showed significant increase in total leukocytes count values compared to control 
group. The results are shown in below table 5. 
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Table .5 Effect of crude ethanolic extract of Annona recticulata of Humoral 
Antibody titre. 
Sl. No Group Mean Leukocyte count 
I Control 5.01×103 cu.mm± 0.2640 
II Annona recticulata 100 mg/kg 6.93×103 cu.mm± 0.2461* 
III Annona recticulata 500 mg/kg 9.56×103 cu.mm± 0.3101** 
IV Levamisole 50 mg/kg 15.01×103 cu.mm± 0.1381*** 
 
          n= 6, total leukocyte count means ±SEM (*P<0.05, **P<0.01, ***P<0.001) 
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7.6 Determination of Total Serum Protein  
The effect of test extract and standard drugs on Total serum protein in wistar 
rats, administration of ethanolic extract of Annona recticulata at the dose of 
(100,500 mg/kg) and Levamisole 50mg/Kg treatments which were given orally for 
14 days. The low dose of extract (100 mg/kg) and large dose (500 mg/kg) standard 
drug Levamisole 50mg/Kg showed significant increase in total serum values 
compared to control group. The results are shown in below table 5. 
Table 6. Effect of crude ethanolic extract of Annona recticulata of total serum 
protein 
Sl. No Group Total serum protein (g/100 ml) 
I Control 7±0.1201 
II Annona recticulata 100 mg/kg 8.5±0.952 
III Annona recticulata 500 mg/kg 10.6±0.1012 
IV Levamisole 50 mg/kg 14.1±0.010 
 
n= 6, total serum value means ± S,D 
Fig. 11 Show Total Serum Protein 
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7. DISCUSSION 
Plants serve as vast source for varied phytoconstituents exhibiting varied 
pharmacological property. Identifying such potential plants is of significance in 
medicine. In the treatment of a disease the toxicity and resistance of available drugs 
are the major world-wide problem. Because of these the designs of new drug which 
can overcome resistance as well as toxicity become one of the leading areas of drug 
design. 
In light of this, in the present study; widely available herb Annona reticulata 
was selected for Pharmacognostical standardization according to WHO guidelines, 
thorough phytochemical analysis followed by pharmacological screening for 
immunomodulatory activity in Wistar rats. 
After the standardization, the shade dried plant material was subjected to 
detailed phytochemical analysis. The various chemical and acid treatments of the 
fruits of the study established the identity of categories of phytoconstituents. The 
fruits were subjected to soxhlet extraction using ethanol as solvent. Later the 
extracts were subjected to preliminary phytochemical analysis to ascertain the 
presence of various categories of phytoconstituents. The preliminary phytochemical 
screening revealed the significant presence of alkaloids, trepenoids, saponnins, 
flavanoids, tannins, phenolic compounds and carbohydrates. 
Acute toxicity study was evaluated by using ethanolic extract on Wistar rats, 
and increasing the concentration of plant extract found to be most effective at low 
dose (100 mg/kg), where as high dose (500 mg/kg) of ethanolic extract of Annona 
recticulata was moderately effective in modulating immune system. 
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The study was carried out using four different methods, each of which 
provides information about effect on different components of the immune system 
(Wagner 1984) 
Delayed Type Hypersensitivity Test was done to study the effect at crude 
aqueous and crude ethanolic extract on cell-mediated immune response to paw 
edema in 24, 48 hrs and then after 72 and 96 hrs paw volume significantly increase 
when compared with control. But in case of standard drug (Levamisole) compared 
with test drug, standard drug show significance paw volume.ethanolic extract of at 
the dose of (100 & 500 mg/kg) and Levamisole 50mg/Kg treatments which were 
given orally for 14 days showed highly significant increase in antibody titre values 
compared to control group 
Humoral antibody titer assay is one of the key parameter used to assess the 
humoral immune response of the animal. As the antigen is expected to induce the 
production of antiserum against it, in the present study sheep red blood cells were 
used to elucidate the production of antibody against RBC. In a individual where 
immune system is primed antibody against a particular antigen is expected to be at 
higher titer. Accordingly in the present study a very high humoral antibody titer was 
recorded and group II and group III individual which received the lowest 
concentration (100 mg/kg and 500 mg/kg) of test drug. On the contrary higher 
concentrations of the drug have surprisingly reduced the HA titer. Pradhan et al 
(2009) administered extract of herbal product to albino rats showed a increased HA 
titer when drug was used at a concentration of 50mg/kg. Similarly BinHafeez  et al 
(2003) also showed increased HA tire at doses of 50 mg/kg and above, of fenugreek 
extract administered on mice. The study showed that up to 300mg/kg of the crude 
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drug could enhance the humoral immune response. Upon examining the present 
results it is evident that the ethanolic extract at concentrations less than 500 mg/kg 
induces humoral immune response as evidenced by HA titer. 
One of the earliest immune response can be seen and measured by studying 
the hematological parameters of an animal. Accordingly parameters like total 
leukocyte count for control group as well as group which received various 
concentrations of drug. Blood cells are the first cells to be responding to invading 
non self materials. An immunomodulatory effect of any immune substance would 
first see as a change in leukocyte count.  In the present study group IV which 
received  (50 mg/kg) of  standard drug showed highest leukocyte count of15.01×103 
cu.mm  showing the initial triggering of blood cell to mount a potent immune 
response. The results showing standard drug concentration are better to elicit good 
immune response than test concentrations (100 mg/kg, 500mg/kg) of drug 
administered. The results are further strengthened with highest percentage of 
neutrophil being circulated in the group. 
Serum protein is one of the earliest indicators of normal serum chemistry of 
an individual. A change in serum protein concentration and albumin ratio would hint 
us about the altered immune response status of the individual. Accordingly in the 
present study serum protein level is found to be similar in case of control and higher 
concentration (500 mg/kg) of the drug but in the lower concentration 100 mg/kg of 
drug test the group showed increase in serum protein showing that higher immune 
response might have contributed to the serum protein in terms of different molecules 
such as immunoglobulin and other humoral factors. The serum protein increased in 
case of Levamisole 50 mg/kg administered by oral.    
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9. CONCLUSION 
 Many of the Annona species have been reported for immunomodulatory 
activity. However, Annona recticulata fruits not been reported for the same. 
 Phytochemical studies showed alkaloids, Phenolics, Flavanoids, 
carbohydrate, terpenoids, steroids, and saponins. 
 Acute toxicity study was done and no mortality reported at doses between 50 
mg/kg to 500 mg/kg. 
 Determined Delayed type hypersensitivity response show significance paw 
volume of lower and higher concentration as compared to control. 
 Evaluation of Humoral antibody titre value showed highly significant 
increase in antibody titre values compared to control group 
 Determined the low dose of extract (100 mg/kg) show effect on TLC count 
compared to control group 
 Estimation of total serum protein show significant increase of total serum 
value compared to control. 
 Ethanolic extract of fruits of Annona recticulata showed moderate 
immunomodulatory activity compared with standard drug. 
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